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Abstract 
 
The mechanism that triggers Alzheimer’s disease (AD) is not well-established, with amyloid plaques, 
neurofibrillary tangles of tau protein, microgliosis and glucose hypometabolism all likely involved in 
the early cascade. One main advantage of animal models is the possibility to tease out the impact of each 
insult on the neurodegeneration. Following an intracerebroventricular (icv) injection of streptozotocin 
(STZ), rats and monkeys develop impaired brain glucose metabolism, i.e. “diabetes of the brain”. Nu-
merous studies have reported AD-like features in icv-STZ animals, but this model has never been char-
acterized in terms of Magnetic Resonance Imaging (MRI)-derived biomarkers beyond structural brain 
atrophy. White matter degeneration has been proposed as a promising biomarker for AD that well pre-
cedes cortical atrophy and correlates strongly with disease severity. Therefore, this project proposes a 
longitudinal study of white matter degeneration in icv-STZ rats using diffusion MRI. An existing image 
processing pipeline was primarily used to obtain preliminary results and propose an optimization strat-
egy to improve it in terms of data quality and reliability. These strategies were tested and implemented 
in the pipeline when confirmed to be valuable, in order to achieve results as reproducible as possible 
and find the spatio-temporal pattern of brain degeneration in this animal model.  
All experiments were approved by the local Service for Veterinary Affairs. Male Wistar rats (N=18) 
(236±11 g) underwent a bilateral icv-injection of either streptozotocin (3 mg/kg, STZ group, N=10) or 
buffer (control group, CTL, N=8). Rats were scanned at four timepoints following surgery on a 14 T 
Varian system. Diffusion data were acquired using a semi-adiabatic SE-EPI PGSE sequence as follows: 
4 (b=0 ms/µm2), 12 (b=0.8 ms/µm2), 16 (b=1.3 ms/µm2) and 30 (b=2 ms/µm2) directions; 
TE/TR=48/2500 ms, 9 coronal 1 mm slices, δ/Δ=4/27 ms, FOV=23x17 mm2, matrix=128x64 and 4 
shots.  
The existing image processing pipeline included image denoising and eddy-correction. Moreover, 
diffusion and kurtosis tensors were calculated for each voxel, producing parametric maps of fractional 
anisotropy (FA), mean, axial and radial diffusivity (MD, AxD and RD) and mean, axial and radial kur-
tosis (MK, AK and RK). Additionally, the two-compartment WMTI-Watson model was further esti-
mated to provide specificity to the microstructure assessment. The following metrics were derived from 
the model: volume water fraction 𝑓, parallel intra-axonal diffusivity 𝐷𝑎, parallel 𝐷𝑒,║ and perpendicular 
extra-axonal diffusivities 𝐷𝑒,ꓕ and dispersion of fiber orientations 𝑐2. Since the model allows for two 
mathematical solutions, the 𝐷𝑎 > 𝐷𝑒,║ solution was retained based on recent evidence. Considering pre-
vious findings, the corpus callosum, cingulum, fornix and fimbria were chosen as white matter regions 
of interest (ROIs) and automatically segmented using anatomical atlas-based registration. Mean diffu-
sion metrics were calculated in each ROI for each dataset. CTL and STZ groups were compared using 
two-sided t-tests at each timepoint. Within-group longitudinal changes were assessed using one-way 
ANOVA. Because of the small cohort, statistical analysis excluded the last time point.  
In the course of this project, strategies to optimize the existing pipeline were developed and tested. 
The existing brain atlas template was supplemented with white matter labels, rat brain extraction was 
semi-automated, and bias field correction of anatomical data was added before registration. Ventricle 
enlargement is typically reported in icv-STZ animals and normally constitutes an issue of misalignment 
in registration. In order to better match the label ROIs with the respective underlying tissue, several 
registration procedures were tested with different FA and color-coded FA template images. Color-coded 
FA-based registration dramatically improved the segmentation of the corpus callosum and the fimbria 
and reliability of diffusion metrics extracted from these regions. Moreover, additional fiber metrics were 
extracted from a newly developed tractography pipeline to compare with tensors metrics and finally, 
tensors metrics were evaluated in the gray matter for a more comprehensive spatio-temporal character-
ization of brain degeneration.     
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Results from statistical analysis were obtained after implementing the successful optimization strat-
egies into the pipeline. There were few significant differences within groups over time. However, be-
tween-group differences at each time point were more pronounced. White matter microstructure altera-
tions were consistent with previous studies of histology and cognitive performance of the icv-STZ 
model. Changes in tensors metrics indicate early axonal injury in the fimbria and fornix at 2 weeks after 
injection, a period of potential recovery at 6 weeks after injection and late axonal injury at 13 weeks in 
all ROIs. The WMTI-Watson biophysical model provided specificity to the underlying microstructure, 
by showing intra-axonal damage in the fimbria and corpus callosum as early as 2 weeks, followed by a 
recover period and definite axonal loss at 13 weeks after injection.  
Results from tensors metrics and the WMTI-Watson model are not only complementary, they are 
consistent with each other and with previously-established trends for structural thickness, memory per-
formance, amyloid deposition and inflammation. The icv-STZ model displays white matter changes in 
tracts reportedly affected by AD, while the degeneration is induced primarily by impaired brain glucose 
metabolism. The icv-STZ constitutes an excellent model to reproduce sporadic AD and should allow to 
further explore the hypothesis of AD being “type III diabetes”. The combination of diffusion information 
extracted from tensor imaging and biophysical modelling is a promising set of tools to assess white 
matter in the AD brain and might be the upcoming strategy to assess the human brain. Regarding future 
work, it will focus on estimating the correlation between microstructural alterations and functional con-
nectivity (from resting-state functional MRI), glucose hypometabolism (from FDG-PET), and patholog-
ical features (from histological stainings) – all currently under processing at CIBM. Tractography is a 
cutting-edge methodology to assess brain connectivity and the pipeline created could be further devel-
oped to improve understanding and support diffusion metrics. The relationship between white and gray 
matter will also improve the understanding of spatio-temporal degeneration and the progression nature 
of the disease.   
 
Keywords: Alzheimer’s disease, animal models, white matter microstructure, diffusion tensors and 
biophysical models of diffusion 
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Resumo 
 
O mecanismo que desencadeia a doença de Alzheimer (DA) não é bem conhecido, contudo sabe-se 
que a presença de placas amilóides e de emaranhados neurofibrilares da proteína tau, microgliose e ainda 
hipometabolismo de glucose estão envolvidos na fase inicial da cascata de desenvolvimento da doença. 
A principal vantagem dos modelos animais é justamente a possibilidade de estudar individualmente o 
impacto de cada um destes mecanismos no processo de neurodegeneração. Após uma injeção intracere-
broventricular (icv) de estreptozotocina (STZ), várias espécies de animais mostraram um metabolismo 
anormal de glucose no cérebro, processo que foi referido como “diabetes do cérebro”. Vários estudos 
demonstraram que animais icv-STZ são portadores de características típicas de DA, mas este modelo 
animal nunca foi estudado em termos de biomarcadores derivados de técnicas de imagem por ressonân-
cia magnética (IRM), exceto atrofia estrutural do cérebro. Um biomarcador promissor de DA que se 
acredita preceder a atrofia do córtex cerebral é a degeneração da matéria branca do cérebro, uma vez 
que foi fortemente correlacionado com a progressão e gravidade da doença. Logo, este projeto propõe 
um estudo longitudinal da degeneração da matéria branca em ratazanas icv-STZ utilizando IRM de di-
fusão. O plano de processamento de imagem existente foi utilizado primeiramente para obter resultados 
preliminares e viabilizar a proposta de estratégias de otimização da mesma, em termos de melhoramento 
da qualidade de imagem e credibilidade das variáveis extraídas das imagens resultantes. Estas estratégias 
foram testadas e implementadas no plano de processamento quando a sua performance confirmou ser 
de valor, para que os resultados fossem o mais reproduzíveis possível em caracterizar a distribuição 
espácio-temporal da degeneração do cérebro neste modelo animal. 
Todos os procedimentos aqui descritos foram aprovados pelo serviço local dos assuntos veterinários. 
Ratazanas macho Wistar (N=18, 236±11 g) foram submetidas a uma injeção icv de STZ (3 mg/kg) no 
caso do grupo infetado (N=10) ou de um buffer no caso do grupo de controlo (N=8). As ratazanas foram 
examinadas no scanner de IRM do tipo Varian de 14 T em quatro momentos no tempo: 2, 6, 13 e 21 
semanas após a injeção. As imagens por difusão foram adquiridas com uma sequência semi-adiabática 
spin-echo EPI PGSE com os seguintes parâmetros: 4 (b=0), 12 (b=0.8 ms/µm2), 16 (b=1.3 ms/µm2) and 
30 (b=2 ms/µm2) direções; TE/TR=48/2500 ms, 9 secções coronais de 1 mm, δ/Δ=4/27 ms, FOV=23x17 
mm2, matriz=128x64 e 4 shots.  
O plano existente de processamento de imagem incluía a correção das imagens ao nível de ruído e 
correntes-eddy. Posteriormente, os tensores de difusão e curtose foram estimados para cada voxel e os 
mapas paramétricos de anisotropia fracional (FA), difusão média, axial e radial (MD, AD e RD) e cur-
tose média, axial e radial (MK, AK e RK) foram calculados. Adicionalmente, um modelo de difusão de 
água nas fibras da matéria branca foi utilizado para providenciar maior especificidade ao estudo da 
microestrutura do cérebro. Como tal, o modelo de dois compartimentos denominado WMTI-Watson foi 
também estimado e as seguintes variáveis foram derivadas do mesmo: a fração do volume de água 𝑓, a 
difusividade paralela intra-axonal 𝐷𝑎, as difusividades paralela 𝐷𝑒,║ e perpendicular 𝐷𝑒,ꓕ extra-axonais 
e, finalmente, a orientação da dispersão axonal 𝑐2.  Este modelo matemático tem duas soluções possíveis 
dada a sua natureza quadrática, pelo que a solução 𝐷𝑎 > 𝐷𝑒,║ foi imposta com base em evidências re-
centes. Considerando estudos anteriores, as regiões de interesse (RDIs) da matéria branca escolhidas 
para analisar a microestrutura cerebral foram o corpo caloso, o cíngulo, a fimbria e a fórnix. Estes foram 
automaticamente segmentados através de registo de imagem de um atlas das regiões do cérebro da rata-
zana e as médias das medidas extraídas dos tensores de difusão e curtose e ainda do modelo biofísico 
neuronal foram calculadas em cada RDI para cada conjunto de imagens obtidas. Os dois grupos de teste 
e controlo foram comparados usando testes t de Student bilaterais em cada momento do tempo, e a 
comparação das alterações longitudinais em cada grupo foi feita usando uma ANOVA. Devido ao baixo 
número de amostras, o último momento no tempo às 21 semanas foi excluído da análise.    
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No decorrer deste projeto, várias estratégias para otimizar o processamento de imagem ou comple-
mentar a análise da informação disponível foram testadas. Nomeadamente, o atlas cerebral da ratazana 
foi aperfeiçoado relativamente às regiões de matéria branca, a segmentação do cérebro foi testada com 
algoritmos automáticos e a correção do bias field em imagens estruturais de IRM foi adicionada ao plano 
antes do registo de imagem. O aumento dos ventrículos cerebrais é uma característica frequente em 
animais icv-STZ, constituindo um problema de alinhamento nos métodos de registo de imagem. No 
sentido de otimizar a correspondência entre as regiões do atlas e as respetivas regiões na imagem estru-
tural e por difusão, vários procedimentos de registo de imagem foram testados. O co-registo de imagem 
convencional utiliza imagens estruturais para normalizar o espaço das imagens por difusão, no entanto 
os mapas paramétricos de FA têm vindo a substituir este conceito dado o excelente contraste que provi-
denciam entre a matéria branca e cinzenta do cérebro. Mapas de FA com diferentes direções predomi-
nantes mostraram uma melhoria significante da segmentação do corpo caloso e da fimbria e também do 
poder estatístico das variáveis extraídas destas RDIs. Adicionalmente, um novo plano de processamento 
de tratografia foi construído de raiz no âmbito deste projeto para extrair variáveis adicionais das fibras 
de interesse e compará-las com as variáveis de difusão obtidas por análise voxel-a-voxel. Por último, as 
variáveis calculadas através dos tensores de difusão e curtose foram avaliadas na matéria cinzenta do 
cérebro para uma caracterização espácio-temporal da degeneração cerebral na DA.  
Os resultados da análise estatística foram obtidos após integrar no plano de processamento as estra-
tégias que mostraram valorizar o projeto em termos de qualidade de imagem ou credibilidade das vari-
áveis. Houve poucas diferenças significativas ao longo do tempo em cada grupo, no entanto as diferen-
ças entre grupos foram bastante acentuadas. As alterações ao nível da microestrutura da matéria branca 
foram consistentes com estudos prévios em animais icv-STZ usando métodos histológicos e avaliações 
das suas capacidades cognitivas. Alterações nas variáveis extraídas dos tensores indicaram deficiência 
axonal inicial na fimbria e no fórnix 2 semanas após injeção no grupo de teste, um potencial período de 
recuperação às 6 semanas e novamente deficiência axonal às 13 semanas, sendo que neste período tardio 
todas as RDIs foram afetadas. O modelo biofísico WMTI-Watson confirmou aumentar especificidade 
ao estudo da microestrutura, visto que demostrou danos intra-axonais na fimbria e no corpo caloso 2 
semanas após injeção, seguidos de um período de recuperação e de perda de estrutura axonal definitiva 
às 13 semanas em todas as RDIs.  
Não só estes dois métodos de análise de IRM de difusão se complementam, como são também con-
sistentes entre eles e com as tendências de alterações ao longo do tempo descritas noutros estudos. Além 
disso, o animal icv-STZ mostrou alterações características da DA, mesmo tendo a degeneração cerebral 
sido induzida pela disrupção do metabolismo de glucose no cérebro. Como tal, este modelo animal é 
excelente para reproduzir a doença e deverá continuar a ser avaliado nas diferentes áreas multidiscipli-
nares para explorar a hipótese de a DA ser desencadeada pela falha do sistema insulina/glucose. A com-
binação da informação de difusão obtida dos tensores e da modelação da difusão neuronal provou ser 
uma ferramenta promissora no estudo das fibras da matéria branca do cérebro e poderá vir a ser o desafio 
futuro no que toca a investigação clínica da DA. Este estudo focar-se-á em correlacionar as alterações 
microestruturais aqui descritas com dados de conectividade funcional (obtida por IRM funcional em 
repouso), hipometabolismo de glucose (por FDG-PET) e outras características patológicas (por colora-
ção histológica) – todos já em curso no CIBM. Tratografia é a metodologia topo de gama para aceder à 
conetividade cerebral e o plano de processamento gerado neste projeto poderá continuar a ser desenvol-
vido no futuro para informação adicional, assim como a relação entre a matéria branca e cinzenta poderá 
suplementar a compreensão da progressão da doença no espaço e no tempo.  
 
Palavras-chave: Doença de Alzheimer, modelos animais, microestrutura da matéria branca cerebral, 
tensores de difusão, modelos biofísicos de difusão.  
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1. Introduction 
 
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder affecting 10% of the popu-
lation over 65 years old. AD is the most common form of dementia and its increasing incidence is lead-
ing to a costly burden of disease. There is no effective cure to AD since brain damage begins 20 years 
before clinical symptoms are evident, which are manifested by cognitive and memory impairment [1]. 
Current approaches to treat AD have failed because at time of symptoms onset, the disease is already 
irreversible. According to the Alzheimer’s Association, due to the rising life expectancy and other en-
vironmental factors, the incidence of AD is expected to quadruplicate by 2050 if no healthcare plan, 
other than palliative care or social support, is provided [2]. Hence, it is of the outmost importance to 
understand the determinants leading to AD development in its long asymptomatic stage.    
According to the report “Health at a Glance 2017” published by OCDE, Portugal is the fourth country 
in the EU with the higher prevalence of dementia, with an average of 1 in each 50 inhabitants having 
dementia. In Switzerland, 1 in each 58 inhabitants suffer from dementia and the tendency of incidence 
is to double in the next 10 years, according to the non-profit organization Alzheimer Switzerland.  
Even though the trigger mechanism of the disease remains unknown, AD is well characterized by a 
pathological cascade of events that defines the temporal progression and severity of the disease, which 
normally ends in dementia because of the late diagnosis [3]. The pathological hallmarks of the cascade 
include aggregation of amyloid-β plaques and neurofibrillary tangles of tau, cortical atrophy, synaptic 
dysfunction, inflammation and hypometabolism of glucose. Understanding the temporal and causal re-
lationships between them might offer the opportunity for an early and efficient detection.  
Fortunately, animal models provide the possibility to tease out the individual impact of each of these 
hallmarks and perform longitudinal studies in a relatively short period of time [4]. Following an intrac-
erebroventricular (icv) injection of Streptozotocin (STZ), animals develop impaired glucose metabolism 
in the brain [5]–[7]. Several studies have reported AD-like features in icv-STZ animals [8]–[12], but 
this model has never been assessed with magnetic resonance imaging (MRI) derived biomarkers.   
MRI has emerged in the 70’s, even though the first clinical MRI scanners have appeared in 1990. It 
relies on generating 3D images by measuring the magnetic moments of particles in resonance. With a 
range of contrasts that provide better image detail than Computed Tomography, MRI has become one 
of the standard non-invasive non-ionizing imaging modalities. Both structural and functional imaging 
have profited from the introduction of MRI, with several applications coming along with it.  In particu-
lar, diffusion-weighted imaging (DWI) was introduced in 1986 and relies on the Brownian motion of 
water molecules to study the underlying microstructure of tissues [13]. Fibrous tissues such as white 
matter tracts present a restricted diffusion which provides contrast to images. The study of skeletal and 
cardiac muscle is one of the applications of DWI, however neuroimaging research has made the most 
promising advances. While ischemic stroke is the killer application of DWI, this technique has brought 
over the past 30 years an incontestable insight into neurodegenerative processes.  
Several approaches have been proposed to model diffusion within the brain. From the simple diffu-
sion tensor imaging to the non-Gaussian diffusivity kurtosis imaging [14], [15], numerous metrics can 
be extracted from DWI data to quantify microstructure. Moreover, biophysical models of neuronal dif-
fusion have emerged to provide specificity to the interpretation of changes, which indicate abnormalities 
in tissue microstructure such as demyelination, inflammation, axonal loss, among others [16], [17]. 
Tractography has become the standard approach to assess brain connectivity using diffusion data [18]. 
White matter degeneration has been proposed as a promising biomarker for AD that well precedes 
cortical atrophy and correlates strongly with disease severity and progression [19]–[21]. Given its ani-
sotropic diffusion properties, white matter tracts have been widely assessed using DWI [22], [23], be-
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cause the diffusion tensor is sensitive to the direction of diffusion. Therefore, this master’s project con-
sisted in a longitudinal study of the white matter microstructure in the icv-STZ rat using DWI. Longitu-
dinal information was expected to contribute to the understanding of the spatio-temporal impact of the 
disrupted metabolism of brain glucose in the white matter tracts as well as of the temporal interplay 
between microstructural damage, amyloid deposition, functional loss and cognitive performance. 
This project occurred in the context of the integrated BSc/MSc in Biomedical Engineering and Bio-
physics of Faculdade de Ciências da Universidade de Lisboa (FCUL) in Portugal and took place at 
Centre d’Imagerie Biomédicale (CIBM), École Polytechnique Fédérale de Lausanne (EPFL) in Swit-
zerland, from September 2018 to June 2019. The main objective of this project was the biological inter-
pretation of neurodegeneration results obtained by an existing processing pipeline of DWI images. From 
an engineering perspective, optimization strategies to improve the processing pipeline and the statistical 
analysis were tested and implemented in the course of the traineeship.  
Theoretical background on AD’s pathological features and the icv-STZ animal model are further 
described in the Section 2.1. MRI principles are shortly explained as well in the Section 2.2 and DWI 
fundamentals and applications are put into neuroimaging context in the Section 2.3, by characterizing 
the standard cutting-edge mathematical models to assess diffusion data. In the Section 2.4, general image 
processing techniques including registration and intensity and noise correction are briefly mentioned. 
The study design is described in the Section 3.1 and the methodology used in this project consists in the 
MRI data acquisition explained in the Section 3.2, the image processing pipeline and the statistical anal-
ysis. The image processing pipeline is divided into the existing pipeline and the optimization strategies. 
The existing image processing pipeline was developed by Dr. Ileana Jelescu and used in previous 
projects. It includes image reconstruction, registration and correction, as well as two different ap-
proaches to assess DWI data.  Namely diffusion and kurtosis tensors and the WMTI-Watson biophysical 
model of the white matter. This pipeline is fully described in the Section 3.3 because it was firstly used 
to obtain preliminary results. Practice using this pipeline provided deep understanding of the processing 
methodology and allowed for the development of strategies towards its optimization.  
These strategies were tested following the purpose and procedure described in the Section 3.4. Opti-
mization strategies were focused on obtaining more efficiently reliable and accurate results in terms of 
data quality and statistical power. They consisted in speeding up some of the steps in the existing pro-
cessing pipeline, improving registration methods and diffusion metrics extraction from available data. 
The Section 4.1 shows the performance of each of these strategies and whether they were an additional 
value to the existing pipeline or not. If so, they were integrated in the pipeline to achieve the final results.  
After image processing, statistical analysis of the measures extracted from tensors and the biophysi-
cal model is described in the Section 3.5. Tests here described allowed for the quantification of changes 
in the white matter microstructure and were computed after integrating in the existing pipeline the strat-
egies that were previously shown to be effective improvements in terms of data quality or reliability. 
Results are shown in the Section 4.2.  
Other strategies were proposed as well in this project to complement the final analysis and take ad-
vantage of the available diffusion data. These included performing tractography and diffusion analysis 
of the gray matter. The purpose and procedure to test these strategies are described in the Section 3.6. 
Additional diffusion analysis did not affect statistical tests as strategies were not meant to replace any 
stages of the processing pipeline, but to support the results from the statistical analysis of diffusion 
metrics in the white matter. The performance of these strategies are shown in the Section 4.3. 
The results from each part of the methodology pipeline are addressed and interpreted in depth in the 
Chapter 5, as well as potential drawbacks of the final optimized processing pipeline and promising ad-
vantages of this project. The consistency of the results presented with the existing literature is evaluated 
and so is the future lines of this project at CIBM towards the understanding of AD progression and the 
spatio-temporal relationship between the hallmarks characteristic of the pathological cascade.   
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2. Theoretical Background 
 
2.1. Alzheimer’s disease 
Alzheimer’s disease (AD) is a progressive multifactorial neurodegenerative disorder without effec-
tive treatment. AD is the most common form of dementia, affecting 10% of the population over 65 years 
worldwide. According to Alzheimer’s Association, the incidence of AD will quadruplicate until 2050 if 
no healthcare plan is provided with its outburst already constituting an economic and social burden [2].  
Over the years, the view of Alzheimer’s disease (AD) has been changing in what concerns to the 
clinical progression of the disease. As recently as 30 years ago, pathological changes and clinical evi-
dence were believed to be independent. The current view of AD is that these occur gradually, with 
dementia being the end stage of many years of accumulation of brain alterations. Dementia might be 
defined as the clinically observable result of the cumulative burden of multiple pathological insults in 
the brain [3], that implies an inevitable course towards the complete loss of autonomy.  
Importantly, it is now well-established that pathological changes begin to develop decades before the 
earliest clinical evidences [1]. According to the clinical stage, the disease has been  divided into three 
phases [24]. The first one is the long asymptomatic phase, in which individuals are cognitively normal 
but might show pathological changes. The second phase is the mild cognitive impairment and consists 
in the early onset of cognitive symptoms, most likely deficits in episodic memory, that do not meet yet 
criteria for dementia but are at high risk for developing AD. The last phase is dementia, in which there 
are irreversible impairments in multiple domains that are severe enough to produce loss of function.  
 
2.1.1. Pathological cascade of AD 
The measurement of biomarkers in longitudinal studies enables the understanding of the interplay 
between them and their relationship to clinical symptoms, being a biomarker defined as any chemical 
or imaging indicator of specific changes that characterize AD. The time-dependent occurrence of dif-
ferent physiological changes could provide an effective disease staging, its expression as clinical 
changes and a prediction of mild cognitive impairment conversion into AD. In that regard, many studies 
have proposed the order in which relevant biomarkers occur in the disease progression [1], [24], [25], 
allowing studies from different disciplines to relate to one another through a common framework. 
AD is clinically manifested by progressive memory loss and gradual decline in cognitive function, 
often culminating in premature death. Neuropathologically, AD is characterized by abnormal protein 
deposits and neurodegeneration. The former includes both amyloid-β (Aβ) plaques in the extracellular 
space and intracellular neurofibrillary tangles of hyperphosphorylated tau (NFTs). Normally, measuring 
the concentration of Aβ42 or tau in the cerebrospinal fluid (CSF) within the ventricles is a way of eval-
uating abnormal plaques deposition, as well as Positron Emission Tomography (PET) imaging. Nearly 
all patients clinically diagnosed with AD have positive amyloid imaging studies [26]. 
In turn, neurodegeneration is manifested as reduced brain glucose metabolism [27] that leads to neu-
ron loss and synaptic dysfunction and these to gross cerebral atrophy [28], especially in the hippocampus 
and parietotemporal cortex [19], [20], [29]–[31]. In this context, AD is commonly assessed either by 
histological post-mortem examinations, anatomical MRI to provide volumetric measures of atrophy or 
2-[18F]fluoro-2-Deoxy-D-glucose (FDG) PET. A decreased uptake of FDG has been well correlated 
with impaired synaptic activity and cognitive decline [32].  
Brain structural atrophy encountered in AD studies in humans refers to both gray and white matter 
degeneration. In terms of the temporal projection of these mechanisms, the emerging hypothesis, though 
not fully established, is that gray matter degeneration begins in the temporal lobe and progresses to other 
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brain areas via degenerating white matter tracts [33]. The most reported gray matter regions early af-
fected are the medial temporal lobe (MTL), the parietal cortex and the posterior cingulate cortex [34], 
while the main white matter tracts affected are the corpus callosum, the cingulum and the fornix [19], 
[35]. White matter degeneration has recently been gathering attention as a key biomarker for AD, being 
strongly correlated with disease severity and progression [19], [21], although its relationship with clin-
ical symptoms is largely under-investigated.  
All these hallmarks of AD occur in a pathological cascade, that is yet to be fully understood. One of 
the proposed temporal progression of pathological changes is shown in Figure 2.1 and suggests that 
malformation of protein precedes neurodegeneration, neurodegenerative biomarkers are temporarily or-
dered and biomarkers abnormalities precede clinical symptoms [1], [24].  
 
 
Figure 2.1: Pathological cascade of AD adapted from Jack et al, 2013 [24]. Evolution of biomarkers over disease progression, 
where white matter degeneration might have a key role. MCI: mild cognitive impairment. 
 
2.1.2. Etiopathology of AD 
There are two origin-based types of AD, despite the indistinguishable clinical symptoms. The early-
onset familial AD occurs in a very small proportion (≈1%) of the population compared to the sporadic 
late-onset AD. Familial AD has a genetic origin and is caused by a mutation in Aβ protein precursor 
(APP), presenilin-1 or presenilin-2. While an abnormal processing of APP leads to the excess production 
and/or reduced clearance of Aβ in the cortex, presinilin mutations encode abnormal cleavage of Aβ from 
APP to generate amyloidogenic Aβ peptides [36]. Nevertheless, the majority of the cases are sporadic 
in origin, with aging, type II diabetes and apolipoprotein E4 as the main risk factors [37].  
The uncertainties associated with the etiopathology and progression of AD have led to intense inves-
tigation over the past years. The most prevailing theory stands in the amyloid cascade hypothesis, where 
neuropathological alterations are downstream consequences of a gradual aberrant Aβ accumulation [38], 
[39], as represented by the Figure 2.1.   
An amyloid is a type of protein susceptible to structural conversion. Amyloid protein aggregation is 
considered a hallmark in several degenerative disorders, depending on the major constituents of the Aβ 
plaques. In AD, Aβ plaques are mainly formed by Aβ40 and Aβ42 peptides, which vary in the amino acids 
present at the C-terminal, resulting in distinct toxicity profiles. Due to environmental and genetic factors, 
Aβ peptides may undergo a toxic process of on-path oligomerization and be transformed into metastable 
structured oligomeric species, contributing to the proliferation of toxic species and the acceleration of 
neurodegeneration. Aβ oligomers affect cellular membranes on multiple levels by inducing endocytosis 
of the cell, influencing cellular signalling transduction, dysregulating the flux through the cell pores or 
being internalized into neurons and accumulated intracellularly [40]. These damaging events induce 
microglia and astrocyte activation and typically involve the presence of NFTs [41]. 
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In accordance, evidence clearly shows that severe amyloidosis triggers familial AD [39], [42]. Yet, 
Aβ has not be proven to be required for the onset and progression of sporadic AD, despite of its early 
occurrence [37], [43]. Evidence indicates that Aβ is normally present in the brain, being in higher levels 
in younger than in older individuals in the absence of dementia [44]. Whereas mutations do not manifest 
dementia until 40 years of age [45], 30% of individuals carrying pre- or post-mortem detected amyloid 
plaques are cognitively intact [46]. In addition, immunotherapy can remove these plaques but does not 
affect the progression of dementia, suggesting that Aβ may not be sufficient to cause dementia [47].  
So far, brain metabolic decline has been assumed to result from Aβ plaques and NFTs aggregation, 
being ultimately associated with dementia [48], [49]. Curiously, dementia has been reported in rodents, 
which do not produce Aβ, implying that the mechanism that triggers the cascade must be prior to Aβ 
aggregation. Hence, the aggregation of Aβ has been questioned as the primary cause of AD, being in-
stead proposed as a secondary consequence of disturbed insulin/glucose metabolism in the brain [43]. 
In the mature brain, most of the insulin derives from the periphery, being transported by the CSF 
after its synthesis in the pancreatic β-cells and a smaller portion is synthetized de novo in the brain. As 
well as in the periphery, insulin actions in the brain are mediated by insulin receptors (IRs), a tyrosine 
kinase type of receptors. As shown in the Figure 2.2, insulin binds to IRs promoting autophosphoryla-
tion of their intracellular domain. Activated IRs phosphorylate intracellular substrates that activate sev-
eral signalling pathways, one of which triggers the translocation of the insulin-sensitive glucose trans-
porter to the membrane surface, enhancing cellular glucose uptake [50]. In addition to be the master 
regulator of brain glucose metabolism, insulin plays a significant role in neuronal growth [51], influ-
ences APP metabolism potentiating Aβ formation [52] and tau phosphorylation [53] and is involved in 
synaptic plasticity by altering gene expressing required for long-term memory consolidation [54]. 
 
 
Figure 2.2: The role of insulin in the cellular membrane. PI-3K and PKB/Akt: signalling pathways. GLUT4: glucose trans-
porter [51]. 
 
It has been reported that AD patients have higher levels of plasma insulin as well as decreased IR 
density and reduced tyrosine kinase activity [55] reinforcing the idea that abnormalities in brain insulin 
function and insulin signal transduction are major factors that influence the onset of AD [50]. It has also 
been shown that insulin administration improves cognitive performance in AD patients [56]. In that 
regard, reductions in brain glucose have been shown to decrease the rate of acetyl-coenzime A suggest-
ing a causal role of glucose metabolism dysfunction in the loss of cognitive function [57].  
Other less acknowledged hypotheses for the primary cause of development and progression of AD 
are tau pathology, synaptic loss and inflammation [58]. 
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2.1.3. Animal models of AD 
One problem in investigating neurodegenerative disorders is obtaining comprehensive longitudinal 
data on prospective patients. Longitudinal studies in animals are of particular interest because the study 
can be designed across their entire lifespan, whereas many years would have to be dedicated to capture 
the human lifespan. Besides, animal models allow studying each of the characteristics and the disease 
stages individually, which is particularly important when multiple domains are affected simultaneously.  
Independent mechanisms can be studied separately by biologically modifying the animals, with an 
increasing use of rodents to reproduce AD. Transgenic mouse models of AD are very common in re-
search and focus on reproducing protein mutations, namely APP, presinilin or tau protein. The mouse 
models most used in current AD research are the triple transgenic model (3xtg AD) and the 5XFAD 
(Tg6799) mouse line. Whereas transgenic mice are naturally representative of familial AD, the sporadic 
form of AD is reproduced without genetic modifications. With AD being increasingly recognized as an 
insulin-resistant state, a non-transgenic animal model has emerged to reproduce early pathological 
changes of sporadic AD [5], [6], [59]. This model consists in an intracerebroventricular (icv) injection 
of streptozotocin (STZ), which is a toxic diabetogenic substance that damages pancreatic β cells when 
given parenterally. When injected exclusively into the ventricles, STZ does not induce type I diabetes 
because the molecule cannot pass across the blood brain barrier to reach the systemic circulation. For 
that reason, icv-STZ induced-AD has been referred to as type III diabetes or “diabetes of the brain” [11].  
Even though its mechanism is not fully elucidated, STZ is thought to disrupt the brain IR system 
thereby reducing the glycolytic metabolism in the parietotemporal cortex and in the hippocampus [7]. 
Accordingly, behavioural, neurochemical and structural features reported in icv-STZ studies resemble 
those found in the human AD brain, validating this experimental model. Several icv-STZ animals such 
as mice, rats, dogs, pigeons, monkeys and pigs have been studied and displayed features including 
memory impairment, thinning of the parietal cortex and corpus callosum, NFT changes and extracellular 
accumulation of Aβ early in the neocortex and later in the hippocampus [9]. Focal lesions on the corpus 
callosum and on the septum were found in the form of neuronal loss and inflammation, as well as atrophy 
of the entorhinal, cingulate cortex and hippocampal regions [8]. In addition, histopathological studies 
have shown evidence of axonal damage and demyelination in the hippocampus and fornix, where ab-
normal transport of nerve growth factor has been reported. More than disrupting brain glucose metabo-
lism, STZ also induces oxidative stress to which myelin is particularly vulnerable [8]–[12].  
The icv-STZ model has been demonstrating its potential to reproduce sporadic AD [60]. However, 
beyond anatomical MRI, all icv-STZ studies have used histology, immunohistochemistry, PET and elec-
tron microscopy derived-biomarkers. Pathological alterations typical of this animal model have never 
been assessed with MRI techniques, which have brought a significant insight into neurodegenerative 
processes with such a broad spectrum of contrast mechanisms as described in the Section 2.2. This 
scenario opens a window for future investigation, provided that white matter degeneration has been 
repeatedly reported in icv-STZ studies and a unique way to assess brain microstructure is diffusion 
weighted imaging (DWI), as explicated in detail in the Section 2.3.  
 
2.1.4. Relevant rat brain anatomy 
AD has been highly associated with degeneration in the hippocampus as one of the explanations to 
high memory deficits. The hippocampus is a major component of the brain, located in between the me-
dial temporal lobes (MTL) and is composed of several subparts such as the dentate gyrus, cornus am-
monis and subiculum. There are two groups of fibers covering its communication with the brain: the 
myelinated tract that connects the ventricle part of the hippocampus is designated by alveus, while the 
tract that covers the temporal part of the hippocampus is the fimbria-fornix complex. This complex is a 
C-shaped structure composed by fiber bundles that are mainly output tracts of the hippocampus. 
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The fimbria is composed by two separated bundles on the left and right sides that leave the hippo-
campus and go to a posterior and superior location around the thalamus where the bundles take the name 
of crura of the fornix. These are intimately connected with the under surface of the corpus callosum and 
come together in the midline of the brain forming the body of the fornix. Between the corpus callosum 
and the fornix lies a transparent membrane composed of white matter fibers referred to as septum. The 
two hippocampi are thus connected by the hippocampal commissure. Going along with the corpus cal-
losum to the anterior part of the brain, the fornix is divided into two arches and meet the mammillary 
bodies. The function of this complex in the physiology of the brain is not entirely understood, although 
the fimbria and the fornix are thought to be related to learning and memory processes intermediation.   
As a wide, thick and flat tract across the entire brain, the corpus callosum is the largest white matter 
structure there is. It is a bundle of commissural fibers beneath the cerebral cortex and above the fornix 
and it connects the left and the right cerebral hemispheres enabling communication between them. The 
corpus callosum is divided into several parts depending on the coronal position. Towards the frontal 
lobe, the bundles are designated genu, whereas towards the occipital lobe and the cerebellum the bundles 
are designated splenium. Behind the splenium stands the retrosplenial cortex (RSC), whose function 
might be related to mediating perceptual and memory functions. 
The trunk of the corpus callosum is located in the middle of the brain and connects exactly the two 
sides of the temporal lobe, through a tract named anterior commissure. The cortices are connected to 
inferior parts of the brain through the numerous ramifications of the corpus callosum, in particular the 
external capsule. The posterior parietal cortex (PPC) is on top of the corpus callosum and is responsible 
for receiving information from somatosensory systems.  
Right above the corpus callosum is the cingulum, which is composed of two groups of fibers in a C-
shaped structure as well. The cingulum is located beneath the cingulate cortex from where fibers are 
projected into the entorhinal cortex and the RSC. The anterior cingulate cortex (ACC) controls emotion 
such as apathy and depression, while the posterior part of the cingulate cortex is in charge of cognitive 
function such as memory. While establishing the communication between these regions, the cingulum 
has a serious role in the correction of mistakes, appraisal of pain and reinforcement behaviour. These 
regions are represented in the Figure 2.3.     
 
 
Figure 2.3: Anatomy of the rat brain from the Allen Brain Atlas in a coronal plane. Regions in purple correspond to white 
matter tracts.  
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2.2. Magnetic Resonance Imaging principles 
2.2.1. Alignment and precession of magnetic moments 
The atom is the smallest constituent unit of ordinary matter and is composed of protons, neutrons 
and electrons. Electrons are negatively-charged and orbit around the atomic nucleus that is composed 
by positively-charged protons and uncharged neutrons. In quantum mechanics, elementary particles 
such as atomic nuclei carry an intrinsic angular momentum called nuclear spin. The spin assumes two 
possible values (-½ and +½) and the proportion of populations in each of the two states is given by the 
Boltzmann distribution which gives the relative weight of magnetic energy to thermal energy. However, 
while this is a purely quantum phenomenon, a convenient classical description might be used to explain 
it. Herein, MRI is explained with an illustrative classical approach.    
From the classical physics point of view, the spin is viewed as the rotational motion of the nuclei 
around their own axis and the principles of MRI rely on that spinning motion of specific nuclei present 
in biological tissue. Following the laws of electromagnetic induction, when a charged nucleus is spin-
ning, it acquires a magnetic moment and therefore is able to align with an external magnetic field. In the 
absence of an external magnetic field, the orientations of the nuclear spins are random. Contrarily, when 
a magnetic field 𝐵0 is applied, the magnetic moments of the nuclei are capable of aligning in either a 
parallel or anti-parallel direction. These two states of energy are explained by quantum physics that 
describes the properties of electromagnetic radiation in terms of discrete quantities.  
The parallel aligning nuclei are the low-energy population that does not have enough energy to op-
pose 𝐵0 and therefore the magnetic moments align in the same direction as the 𝐵0. On the contrary, the 
anti-parallel nuclei are the high-energy population that opposes 𝐵0 and aligns in the opposite direction 
of 𝐵0. Naturally, the low-energy population is larger and there is a small excess of magnetic moments 
in the parallel direction. The energy difference between the two populations produce a net magnetic 
moment which is proportional to the strength of 𝐵0. The higher the 𝐵0, the fewer nuclei in the anti-
parallel state, the higher the energy difference and the larger the magnetization, that ultimately improves 
the MRI signal. The alignment phenomenon is shown in the Figure 2.4. 
 
 
Figure 2.4: Alignment of nuclear spins with no external field applied (on the left) and in the presence of 𝑩𝟎 (on the right) 
[61]. NMV: net magnetization vector.  
 
Every nucleus that makes up the net magnetization is spinning on its own axis with one of two ori-
entations. In addition, the influence of 𝐵0 produces another rotation of the magnetic moment around 𝐵0, 
which is called precession and is shown in the Figure 2.5. The speed at which the net magnetization 
precesses around 𝐵0 is called precessional frequency 𝑤0 and depends on nuclei properties, such as the 
gyromagnetic ratio 𝛾, as stated by the Larmor equation in the Equation 4.1 [61]–[63].  
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In particular, hydrogen creates a large net magnetization after aligning with 𝐵0 since it is relatively 
more abundant in biological tissue than other species and hydrogen nuclei have a large gyromagnetic 
ratio. Providing that the gyromagnetic ratio of the hydrogen nuclei is 42.57 MHz/T, if an external field 
of 14.1 T is applied, their precessional frequency is roughly 600 MHz.  
 𝑤0 = 𝐵0 𝛾 [4.1] 
 
 
Figure 2.5: Precessional movement of the net macroscopic magnetic moment induced by 𝑩𝟎 [61]. 
 
2.2.2. Resonance phenomenon 
Acquaintance with the precessional frequency is fundamental to produce resonance of a nucleus and 
produce a moving magnetic field that can finally be captured by a coil to acquire an MRI signal. The 
phenomenon of resonance occurs when a nucleus precessing in its natural frequency is exposed to an 
external perturbation with an oscillation with similar frequency and gains energy from the interaction. 
For resonance of hydrogen to happen, a radio-frequency (RF) pulse at frequency equal to the hydrogen’s 
precessional frequency must be applied. Other nuclei that have aligned with 𝐵0 do not resonate because 
their precessional frequency is different from that of the hydrogen. 
As a result of resonance, the absorption of energy from the RF pulse by the nuclei increases the high-
energy population as some of the low-energy nuclei gain enough energy to oppose 𝐵0. With a balanced 
number of nuclei in both populations, the longitudinal component of the magnetization is completely 
transferred into the transverse plane and is no longer affected by 𝐵0 as shown in the Figure 2.6. The 
angle at which the net magnetization moves relatively to 𝐵0 direction is called flip angle and depends 
on the amplitude and duration of the RF pulse. The transverse component of the magnetization rotates 
at the Larmor frequency and the magnetic moments of the hydrogen nuclei move in phase with each 
other.  
 
 
Figure 2.6: The net magnetization vector (NMV) is completely transferred from the longitudinal to the transverse plane after 
a 90° RF pulse as a resonance result [61]. 
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When the RF pulse is switched off, the net magnetization is influenced by 𝐵0 again and realigns with 
it, by losing the energy it has acquired from the RF pulse. The process of returning to the original lon-
gitudinal alignment is called relaxation and consists in two phases, namely the recovery phase and the 
decay phase. The recovery phase is the exponential increase of longitudinal magnetization while the 
nuclei transfer energy to the surroundings – spin lattice relaxation, with a time constant T1. The decay 
phase is due to the transfer of energy to other nuclei – spin-spin relaxation and it represents the expo-
nential decrease of transverse magnetization with a time constant T2 < T1.  
According to Faraday’s laws of induction, a voltage is produced in a receiver coil when it experiences 
a time-varying magnetic flux through its cross-section. The precessing net magnetization produces such 
a time-varying magnetic flux in a receiver coil if the coil axis is perpendicular to 𝐵0, i.e. is parallel to 
the transverse plane. The induced voltage across the coil, and of the electric current flowing in the coil 
as a result, are proportional to the amplitude of the transverse magnetization. When the RF pulse is 
switched off, the transverse magnetization starts decaying and so does the voltage amplitude in the re-
ceiver coil. This reduced signal in induction is designated free induction decay [61]–[63]. 
   
2.2.3. Pulse sequence parameters and image contrast 
Image contrast can be produced by exploiting T1 and T2 relaxation differences between different 
types of tissues. Fat tissue and water, for instance, have completely different properties that make them 
appear with opposite contrasts in the MRI image. Considering that relaxation relies on giving up energy, 
in fat tissue, the slow molecular mobility makes recovery and decay very efficient so that the net mag-
netization realigns quickly and leads to a short T1 and T2. Regarding to water, the high molecular mo-
bility makes recovery and decay less efficient, so that the net magnetization takes longer to realign and 
leads to long water T1 and T2. This is shown in the Figure 2.7. 
The amount of T1 relaxation that has occurred is determined by the time between RF pulses, which 
is called time of repetition (TR). The amount of T2 relaxation is controlled by the time of echo (TE), 
which is the interval between the application of the RF pulse and the peak of the signal induced in the 
coil. TR and TE are specifically set in a pulse sequence and their combination gives rise to different 
contrast mechanisms. For instance, in T2-weighted images, since water has a longer T2 than fat tissue, 
it takes longer to lose its transversal magnetization. Thus, the signal amplitude of the water in the re-
ceiver coil is larger and water appears bright and fat tissue dark. The maximum contrast between tissues 
in T2-weighting occurs when there is the major difference in the transversal magnetization. Because TE 
controls the amount of T2 decay, it controls the amount of T2-weighting. The contrary applies to T1-
weighted images. 
 
 
Figure 2.7: Difference of image contrast between fat tissue and water as a function of time parameters in a T2-weighted im-
age [61]. 
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The most standard pulse sequences in MRI acquisitions are spin-echo and gradient-echo. Spin-echo 
pulse sequences are characterized by having a 180º RF pulse after the initial 90º RF pulse, because of 
the so-called T2* decay. This decay is faster than the T2 decay because it also accounts for the effect of 
the magnetic field inhomogeneities that may cause spatial variations in precessional frequencies depend-
ing on the magnetic field experienced at a given location. To compensate for the dephasing induced by 
these variation, the 180º RF pulse rephases all nuclei by flipping magnetic moments to the opposite 
longitudinal magnetization and with the same transverse magnetization. After the 180º RF pulse, a max-
imum signal is induced in the coil generating an individual spin-echo used to create an image [61]–[63].  
In a different approach, the gradient-echo pulse sequence uses variable magnetic fields that cause 
nuclei to precess at variable frequencies along the direction of the applied magnetic field gradient, lead-
ing to a phase shift. While a first gradient induces magnetic moments within the transverse magnetiza-
tion to dephase, a consecutive gradient with reversed polarity and double the duration time rephase them, 
inducing a signal in the coil called the gradient echo. Unlike the spin-echo, the dephasing and rephasing 
occur in the same direction and do not cancel inhomogeneity effects. These pulse sequences are illus-
trated in the Figure 2.8. Many other sequences have been proposed according to the quality image re-
quired in each study [61].  
 
 
Figure 2.8: Spin-echo (A) and gradient-echo pulse sequences (B). 
   
2.2.4. Signal acquisition and image reconstruction 
Considering that the value of the magnetic field sets the precessional frequency at which nuclei pre-
cess, if the outer field is no longer homogeneous and there is a spatial gradient, nuclei in different regions 
will precess at different frequencies. This is the basis of MRI ability to spatially locate signals. Spatial 
encoding is performed by using three coils placed in the main directions. The magnetic field gradient is 
achieved by overlapping the field of these coils and its direction is determined by the combination of 
their orientations. The first encoding is the slice selection gradient and the frequency of the RF pulse 
defines the slice of the image and its thickness. The second encoding is called phase encoding and locates 
the signal along the short axis of the anatomy. From the moment each position in the short axis corre-
sponds to a different phase, the various elements in that position are encoded by the frequency encoding 
gradient. This is perpendicular to the phase encoding gradient and defines the field of view (FOV).   
At the end of all encoding, the signal coming from each slice is phase and frequency encoded.  When 
applying the frequency encoding gradient, an echo is produced and corresponds to a real time series of 
measurements. The successive application of increasing phase selection gradients leads to the variation 
of these echoes according to TR. The echoes recorded in each TR are stored in an abstract spatial-
frequency domain matrix, designated k-space, as shown in the Figure 2.9. The horizontal axis of the k-
space is the phase information (kPE) while the vertical axis corresponds to the frequency (kFE). By ap-
plying the Fourier transform to the sampled time-dependent signal, the various frequencies specific to a 
point in the image are calculated and the image is able to be reconstructed.  
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Figure 2.9: At each TR, echoes are stored in the frequency and phase encoded k-space to produce an image by applying a 
Fourier transform [63]. 
 
The simplest way to fill in the k-space is to start filling it sequentially line by line from bottom to 
top. However, this form of acquisition is slow and may limit clinical applications. In order to suit the 
circumstances at scan, other forms of acquisition are available such as fast spin-echo pulse sequences or 
echo-planar imaging (EPI). As suggested by its name, fast spin-echo is a spin-echo pulse sequence with 
scan times shorter than the conventional spin-echo, by filling out more than one line of the k-space per 
TR. This is achieved by using a train of several 180º RF pulses, each rephasing the spins and producing 
several echoes that lead to different phase encoding steps at each TR [61].  
Taking the fast spin-echo to the limits, EPI fills all lines after one repetition [64]. The train of RF 
pulses is applied and afterwards, instead of filling out each line in the same direction from the left to the 
right, the k-space is filled in a spiral form beginning at the center. Not only does the frequency encoding 
oscillate to fill lines from left to right and then right to left, the phase encoding must also oscillate from 
bottom to top and then top to bottom. EPI has a huge potential in clinical applications due to its rapid 
data acquisition and sensitivity that can capture physiological motion. Despite all these advantages, the 
rapid switching of gradients causes severe noise vibration of the system. 
Both spatial resolution and signal-to-noise ratio (SNR) characterize the image quality in MRI. The 
SNR is the ratio between the amplitude of the signal received and the average noise of the image. MRI-
derived noise is generated both by physiological motion and thermal noise. In order to be minimized, 
the signal must be increased so that the SNR increases as well. Several factors affect the SNR, namely 
a high proton density, the thickness of slices or a wide FOV increase the SNR, although the latter will 
increase the partial volume effect [65]. Approaches for noise correction of images are described in the 
Section 2.4.   
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2.3. Assessing microstructure with diffusion-weighted imaging 
2.3.1. Biological diffusion principles 
Diffusion is a random transport phenomenon which describes the transfer of material, such as ions 
and molecules, from one spatial location to another over time. From the physical point of view, diffusion 
is characterized by the random walk of the diffusion particles, also known as Brownian motion. The 
Brownian net movement of particles suspended in a fluid result from their collision with fast-moving 
particles in that fluid, where there is no preferential direction. 
The massive amount of interactions that yield the Brownian pattern (roughly 1014 collisions/s) cannot 
be solved by classical mechanics models that account for every involved molecule. Therefore, probabil-
istic models must be used to consider a collective motion of particles in the assessment of how far a 
Brownian particle travels in a given time interval. In 1905, Einstein developed the Brownian theory to 
find the relationship between the diffusion coefficient and the mean squared displacement of particles 
in random motion [66]. When the particle position is incremented over time in a space 𝑥 with a random 
variable ∆ with a probability density function 𝜑(∆), the density of diffusion particles is given by an 
expansion in a Taylor series, as shown in the Equation 4.2. The second order of probability of displace-
ment in the Equation 4.2 might be interpreted as the mass diffusivity 𝐷, such that the density of particles 
at point 𝑥 and at time 𝑡 satisfies the diffusion equation in the Equation 4.3. 
 
𝑑𝜌
𝑑𝑡
=
𝑑2𝜌
𝑑𝑥2
∫
∆2
2𝜏
 𝜑(∆)𝑑∆
+∞
−∞
+ higher order odd terms [4.2] 
 𝑑𝑝
𝑑𝑡
= 𝐷
𝑑2𝜌
𝑑𝑥2
 [4.3] 
Assuming that N particles start from the origin at the initial time 𝑡 = 0, the diffusion equation has a 
solution with a Gaussian distribution with mean 𝜇 = 0 and variance 𝜎2 = 2𝐷𝑡 given by the Equation 
4.4, which shows that the spread of particles increases with elapsed time. Evidently, when 𝜌(𝑥, 𝑡) = 0, 
since a molecule is equally likely to diffuse in a positive or negative x-direction, the average displace-
ment is zero. Therefore, the average square of the displacement can be considered instead, which is 
shown to be proportional to the elapsed diffusion time in the Equation 4.5 [66]. 
 
𝜌(𝑥, 𝑡) =
𝑁
√4𝜋𝐷𝑡
𝑒−
𝑥2
4𝐷𝑡 [4.4] 
 ∆𝑥2̅̅ ̅̅ ̅ = 2𝑁𝐷𝑡 [4.5] 
In the current context, the diffusion coefficient of pure water at 20 ºC is 2 µm2/s and increases at 
higher temperatures, according to the equation of the ideal gas law. Water diffusion is primarily caused 
by random thermal fluctuations and is modulated by interactions with cellular membranes and orga-
nelles. While cellular membranes hinder the extracellular diffusion of water, causing water molecules 
to take more tortuous paths and thereby decreasing the mean squared displacement, intracellular water 
tends to be more restricted. In fibrous tissues, water diffusion is relatively unimpeded in the direction 
parallel to the fiber orientation and hindered in perpendicular directions. Thus, diffusion in fibrous tis-
sues is anisotropic as opposed to homogeneous unrestricted media.  
To describe anisotropic diffusion, a diffusion tensor was introduced in the normal distribution of 
particles defined by the Equation 4.6 [22], [23]. The tensor is a 3x3 covariance matrix that describes the 
diffusion displacement in three dimensions of a single voxel. The diagonalization of the matrix is a 
common procedure as diffusion coefficients become independent of the orientation of the reference 
frame. It yields the eigenvalues (𝜆1, 𝜆2, 𝜆3) and corresponding eigenvectors (𝜖1, 𝜖2, 𝜖3) of the diffusion 
tensor that correspond to the directions and apparent diffusivities along the axes of principal diffusion, 
that are obtained with the Equation 4.7.  
 14 
 
 
𝐷 = [
𝐷𝑥𝑥 𝐷𝑥𝑦 𝐷𝑥𝑧
𝐷𝑦𝑥 𝐷𝑦𝑦 𝐷𝑦𝑧
𝐷𝑧𝑥 𝐷𝑧𝑦 𝐷𝑧𝑧
] = [
𝐷𝑥𝑥′ 0 0
0 𝐷𝑦𝑦′ 0
0 0 𝐷𝑧𝑧′
] [4.6] 
 
𝐷 = [𝜖1 𝜖2 𝜖3]𝑇 [
𝜆1 0 0
0 𝜆2 0
0 0 𝜆3
] [𝜖1 𝜖2 𝜖3] = ∑ 𝜖𝑘
𝑇𝜆𝑘𝜖𝑘
3
𝑘=1
 [4.7] 
The diffusion tensor may be visualized as an ellipsoid, whose directions of the principal axes are 
characterized by the eigenvectors and the radii by the eigenvalues [22], [23], as shown in the Figure 2.10. 
When diffusion is isotropic, the ellipsoid resembles a sphere and eigenvalues are nearly equal (𝜆1 ≈
𝜆2 ≈ 𝜆3), whereas an anisotropic medium is represented by an ellipsoid with significantly different ei-
genvalues magnitudes (e.g. 𝜆1 > 𝜆2 > 𝜆3). The major diffusion eigenvector represents the direction of 
greatest diffusivity and it is assumed to be parallel to the main tract orientation. This directional rela-
tionship is the basis for diffusion tensor image metrics and tract reconstruction algorithms.  
Therefore, diffusion neuroimaging techniques rely on the ability of the diffusion coefficient to pro-
vide information about microstructure. The eigenvalues magnitude might be affected by changes in local 
tissue microstructure such as tissue injury, disease or normal physiological changes such as aging, mak-
ing the diffusion tensor a sensitive probe for characterizing both normal and abnormal tissue.    
 
 
Figure 2.10: A fibrous tissue is an anisotropic medium and can be represented by an ellipsoid with one of the eigenvalue 
magnitudes greater than the others.  
 
2.3.2. Diffusion-weighted imaging and signal representation  
Diffusion-weighted imaging (DWI) is the application of MRI principles to the Brownian water mo-
tion within the human body. DWI is a unique method to describe the microstructure of the brain since 
its characteristic features are able to capture the displacement of water molecules (in 50 ms molecules 
move about 10 µm). The most common approach is the spin-echo pulse sequence with an EPI readout 
and a pair of opposite large-gradient pulses on both sides of the 180º refocusing RF pulse. While the 
first gradient dephases the magnetization across the sample, the second rephases the magnetization. 
 In stationary molecules, the phases induced by both gradient pulses completely cancel and the mag-
netization is maximally coherent, producing no signal attenuation from diffusion. Conversely, when 
there is coherent flow in the direction of the applied gradient, there is a change in the phase by different 
amounts for each pulse. The net phase difference produced is proportional to the displacement, which 
is described by the distribution in the Equation 4.5. In the presence of diffusion gradients, phase disper-
sion of water molecules generates attenuation of the signal 𝑆, i.e. contrast.  
Without any a priori assumptions about the medium, the signal might be represented by a Taylor 
series called the cumulant expansion as shown in the Equation 4.8, where 𝑆0 is the DWI signal without 
any gradients, 𝑏 is the diffusion-weighting factor that characterizes the gradient pulses,  K is the kurtosis 
of the diffusion tensor that quantifies complexity and inhomogeneity of the medium [14] . 
 ln (
𝑆
𝑆0
) = −𝑏𝐷 +
1
6
(𝑏𝐷)2𝐾 + ⋯ [4.8] 
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The cumulant expansion can be simplified under the assumption that the medium is indistinguishable 
from a Gaussian medium. This distribution requires low diffusion-weighting (low b-values) so that 𝐾 =
0 and uniformity of water distribution occurs in all directions. Thus, for isotropic Gaussian diffusion, 
the signal attenuation is described by the Equation 4.9 [13], with the b-value defined by the Equation 
4.10. In this case, for the expansion up to the first order of the Equation 4.8 to be valid, 𝑏 ≪
1
𝐷𝐾
 [68].  
 𝑆 = 𝑆0𝑒
−𝑏𝐷 [4.9] 
 
𝑏 = 𝛾2𝐺2𝛿2 (∆ −
𝛿
3
) [4.10] 
In the presence of anisotropy, diffusion can no longer be characterized by scalars and requires the 
use of the tensor in the Equation 4.6, that fully describes molecular mobility along each direction. The 
Equation 4.9 should then be rewritten as the combination of all main directions as in the Equation 4.11. 
 
𝑆 = 𝑆0 exp(− ∑ ∑ 𝑏𝑖𝑗𝐷𝑖𝑗
𝑗=𝑥,𝑦,𝑧𝑖=𝑥,𝑦,𝑧
) [4.11] 
In the Equation 4.11, 𝑏𝑖𝑗 are in this case the elements of the b matrix that replaced the b coefficient, 
since the b-value is different in each direction depending on the gradients used. To access the anisotropic 
diffusion effects, the diffusion tensor must be fully calculated, knowing both attenuated and non-atten-
uated DWI signals and collecting the b-values along several gradient directions. The use of the diffusion 
tensor to produce parametric maps is designated diffusion tensor imaging (DTI). 
Although DTI metrics are recognized to characterize water diffusion properties, only part of the in-
formation is being assessed due to the assumption that the displacement function has a Gaussian distri-
bution. Therefore, an extension to DTI has been proposed to quantify the non-Gaussian diffusion. Be-
yond low b-values, i.e. using the cumulant expansion, it is possible to estimate how much the medium 
deviates from the Gaussian distribution and further estimate 𝐾. The use of the kurtosis tensor to produce 
parametric maps is designated diffusivity kurtosis imaging (DKI) [14]. DKI has been gathering attention 
due to its sensitivity to microstructure not captured by the diffusion tensor in multiple clinical areas, 
including stroke [69] and children brain development [68].   
Since b-values are quadratic terms, the 2nd order symmetric diffusion tensor requires measurements 
along at least six directions, while the 4th order kurtosis tensor requires at least 15 measurements. For 
DTI and DKI joint analysis, a minimum total of 21 gradient directions is necessary, even though col-
lecting data along as many directions as possible is recommended to uniformize space sampling and 
increase SNR [70], [71]. Sampling directions are shown in the Figure 2.11. The estimation of 𝐷𝑖𝑗 and 
𝐾𝑖𝑗𝑘𝑙 is generally done by multiple linear regression, and therefore measurements of diffusion in all 
directions require at least two non-zero b-values (shells). In in-vivo experiments, the maximum b-value 
for Gaussian brain DTI is roughly 𝑏𝑚𝑎𝑥 = 1 ms/µm
2 whereas for non-Gaussian brain DKI is 𝑏𝑚𝑎𝑥 = 2 
ms/µm2. Naturally, in ex-vivo, the maximum b-values are higher because diffusion is slower. 
 
 
Figure 2.11: Directional sampling in increasing directions [67]. 
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2.3.3. DWI data assessment using tensor-derived metrics 
As aforementioned, despite being a high-sensitivity and non-invasive method, DWI is an indirect 
probe of the microstructure because its signal needs to be modelled to extract quantitative measures. 
The display and interpretation of 3D image data with diffusion and kurtosis tensors at each voxel must 
be simplified into simple scalar maps, by extracting metrics from the combination of eigenvalues.  
Regarding DTI, although the apparent diffusion coefficient has been extremely successful in clinical 
practice, it is being replaced by direct quantitative measures. For instance, the mean diffusivity (MD) is 
a rotationally invariant measure – independent of the orientation of the reference frame [23]. MD char-
acterizes the overall mean-squared displacement of water molecules in all directions, being equivalent 
to the average of the eigenvalues, as given by the Equation 4.12. Therefore, it is proportional to the trace 
of the diagonalized tensor and can be separated into axial (AxD) and radial diffusivity (RD) according 
to the gradient directions, as shown in the Equations 4.13 and 4.14. 
 
𝑀𝐷 =
𝑇𝑟(?⃗? )
3
=
𝐷𝑥𝑥
′ + 𝐷𝑦𝑦
′ + 𝐷𝑧𝑧
′
3
=
𝜆1 + 𝜆2 + 𝜆3
3
 [4.12] 
 𝐴𝑋𝐷 = 𝜆1 [4.13] 
 
𝑅𝐷 =
𝜆2 + 𝜆3
2
 [4.14] 
While low values of AxD are representative of axonal degeneration, RD appears to be modulated by 
myelin in the white matter and thereby is expected to increase as a result of demyelination in neuro-
degenerative processes. As a combination of diffusivity in each direction, MD is expected to decrease 
due to inflammation or to increase if there is loss of structure resulting in increased water mobility.  
The degree to which diffusion is a function of DWI encoding directions is represented by metrics of 
anisotropy [67]. The most popular invariant metric of anisotropy is the fractional anisotropy (FA) and it 
represents the magnitude of the D that is attributed to anisotropic diffusion. FA varies between 0 (iso-
tropic) and 1 (anisotropic) [72] and is described by the Equation 4.15. 
 
𝐹𝐴 = √
(𝜆1 − 𝑀𝐷)2 + (𝜆2 − 𝑀𝐷)2 + (𝜆3 − 𝑀𝐷)2
2 (𝜆1
2 + 𝜆2
2 + 𝜆3
2)
 [4.15] 
Because of the well-oriented integrity of white matter tracts and their myelin insolation, FA is ex-
pected to be higher within white matter tracts than in gray matter regions in normal conditions. In neu-
rodegeneration, FA is expected to decrease because of fiber dispersion. Even though FA is sensitive to 
a broad spectrum of pathological conditions, different eigenvalues combinations can generate the same 
value of FA [73]. This means that FA recognizes changes in diffusion, but different pathologies such as 
inflammation, demyelination or axonal injury might result in the same change in FA.  
Another relevant metric extracted from the diffusion tensor is the tensor orientation described by the 
major eigenvector direction. Using a color-coded map, the eigenvectors are represented to identify and 
parcelate specific white matter tracts [74]. These maps are hereafter called color-coded FA (CCFA) 
maps. The 3D approach of this metric is called DTI-based tractography [75], and it is greatly appreciated 
to anatomically track white matter bundles, as discussed in the Section 4.3.5.  
Analogous to DTI, DKI defines the mean kurtosis (MK) as the directionally averaged observed kur-
tosis. However, because kurtosis is a 4th order tensor, it is calculated over at least 15 directions  ?̂? and 
MK is solved by averaging projections of the tensor over as many directions as possible, isotropically 
distributed on a sphere, as given by the Equation 4.16. 
 
𝑀𝐾 =
1
4𝜋
∫𝐾(?̂?)𝑑?̂? [4.16] 
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𝐾 provides as well metrics of the axial and radial components of kurtosis. Axial (AK) and radial 
kurtosis (RK) may be represented in terms of the eigenvectors of the diffusion tensor [14], even though 
different definitions have been proposed [76], as shown in the Equations 4.17 and 4.18.  
 
𝐴𝐾 = 𝐾(𝜖1̂) =
𝑀𝐷2
𝜆1
2 𝐾𝑧𝑧𝑧𝑧 [4.17] 
 
𝑅𝐾 =
𝐾(𝜖2̂) + 𝐾(𝜖3̂)
2
=
𝑀𝐷2
2
(
𝐾𝑥𝑥𝑥𝑥
𝜆2
2 +
𝐾𝑦𝑦𝑦𝑦
𝜆3
2 ) [4.18] 
MK, AK and RK are expected to be increasing as long as there is on-going development of the brain, 
because there is a general increase in the complexity of the tissues. However, a variety of physiological 
mechanisms could result in the increase of complexity. A high cellular crowding that happens during 
inflammation for instance would contribute to increase the MK value, even though it is not a matter of 
development. As much as DKI brings complementary value to DTI analysis by extending the signal to 
a non-Gaussian distribution, the empirical representation of DWI still lacks specificity.  
  
2.3.4. Biophysical modelling of DWI data 
In order to address this issue, analytical expressions can be derived from theoretical models as a 
complement to tensors estimation. Models rely on assumptions about the underlying tissue and therefore 
provide specific parameters, whereas the cumulant expression in the Equation 4.8 is universally appli-
cable. In the past few years, several models of neuronal tissue have aroused, with special focus on white 
matter characterization. Such models have common features before establishing their own assumptions 
[17], [77], for instance all models consist in at least two non-exchangeable compartments that represent 
the intra-axonal and extra-axonal spaces. Generally, what differs among the existing models is the ori-
entation distribution function (ODF) 𝜓 of the fibers. The ODF is a continuous distribution that repre-
sents the volume and orientation of the underlying fibers and its assessment depends on the application 
of interest. 
One of the most popular neuronal models is NODDI (Neurite Orientation Dispersion and Density 
Imaging) [78], which uses a Watson ODF and includes CSF as a compartment. Thus, it requires a sub-
stantial amount of diffusion parameters that enforce the fixation of some of them. Therefore, without 
biological validation, the approach of fixating parameters defeats the purpose of biophysical modelling. 
NODDIDA (NODDI with Diffusivity Assessment) [79] has emerged to answer the requirement for sim-
plification, suggesting the exclusion of CSF and consequently releasing the diffusivities.  
Another highly accepted model in animal studies is the WMTI (White Matter Tract Integrity) [16]. 
This model varies from the later by analytically deriving parameters as a function of diffusion and kur-
tosis metrics instead of fitting the signal to non-linear equations describing the diffusion of water. In the 
WMTI-Watson model, represented in the Figure 2.12, the axons are modelled as long narrow cylinders 
that reproduce a highly anisotropic medium. The intra-axonal space is described by a volume fraction 
of water molecules 𝑓 and the parallel intra-axonal diffusivity 𝐷𝑎. The perpendicular intra-axonal diffu-
sivity is negligible at the relevant diffusion times, such that axons are considered to be sticks, with radius 
equal to zero. The bundle of axons is embedded in the Gaussian extra-axonal space that yields the par-
allel 𝐷𝑒,║ and the perpendicular extra-axonal diffusivities 𝐷𝑒,ꓕ. The extra-axonal space is orientationally 
correlated with the fibers, whose orientation is given by the FOD-based parameter 𝑐2 = 〈cos(ψ)
2〉.  
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Figure 2.12: Two-compartment WMTI model providing five parameters [16]. 
 
The diffusion signal can be described in terms of both compartments, as given by the Equation 4.19. 
The first term represents the signal originating from a volume fraction of voxel consisting of intra-axonal 
tissue that is only affected in the axial direction, whereas the second term represents the signal originat-
ing from the remaining extra-axonal volume fraction (1 − 𝑓) that is affected in both axial and radial 
directions. As the signal in each compartment is modelled by the orientation distribution, the Equation 
4.19 is the integral of the fiber ODF across all directions [80], [81].  
 
𝑆(𝑏, ?̂?) = ∫ψ(û) (𝑓𝑒−𝑏𝐷𝑎(?̂?.?̂?)
2
+ (1 − 𝑓)𝑒−𝑏𝐷𝑒,║ −𝑏(𝐷𝑒,ꓕ−𝐷𝑒,║ )
(?̂?.?̂?)2)  𝑑?̂? [4.19] 
Taking advantage of the stable fitting of DKI, analytical expressions of tensors as functions of the 
model parameters can be readily found [77], [81], if assuming axial symmetry of the fiber ODF. Geo-
metric interpretation of diffusion allows for the decomposition of the diffusivity into radial and axial 
directions, where 𝜉 = ?̂?. ?̂? represents the direction and the functions ℎ𝑙 the moments of the fiber ODF 
with l=2,4. Each component is the sum of the diffusion in the intra-axonal and in the extra-axonal spaces 
in that direction weighted by the volume fraction, as shown in the Equations 4.20 and 4.21.  
 ℎ2(𝜉) = 0:𝐷ꓕ = (1 − 𝑓) 𝐷𝑒,ꓕ [4.20] 
 ℎ2(𝜉) = 1:𝐷║ = 𝑓𝐷𝑎 + (1 − 𝑓) 𝐷𝑒,║ [4.21] 
The diffusion tensor can be represented as a function of ℎ2(𝜉) by the Equation 4.22. Using the cu-
mulant expression in the Equation 4.8, the kurtosis tensor can be further represented in the same form 
as shown in the Equation 4.23. The diffusion tensor has two rotational invariants 𝐷0 and 𝐷2 because of 
the implications of axial symmetry while the 4th order kurtosis tensor has three 𝐾0, 𝐾2 and 𝐾4. 
 
𝐷(𝜉) = (1 − 𝑓) (𝐷𝑒,⊥ + ℎ2(𝜉)(𝐷𝑒,∥ − 𝐷𝑒,⊥)) + 𝑓𝐷𝑎ℎ2(𝜉) [4.22] 
 
𝐷2𝐾 = 𝑊(𝜉) = 3((1 − 𝑓) (𝐷𝑒,⊥
2 − 𝐷(𝜉)2 + 2𝐷𝑒,⊥(𝐷𝑒,∥ − 𝐷𝑒,⊥)
2
ℎ2(𝜉)
+ (𝐷𝑒,∥ − 𝐷𝑒,⊥)
2
ℎ4(𝜉)) + 𝑓𝐷𝑎
2ℎ4(𝜉)) 
[4.23] 
Without further simplification, it is impossible to determine all 6 unknown parameters in the model 
(𝑓, 𝐷𝑎, 𝐷𝑒,∥, 𝐷𝑒,⊥, ℎ2 and ℎ4), because there are only 5 rotational invariants from the tensors. By em-
ploying a one-parameter family of axially symmetric ODFs, ℎ2 and ℎ4 contain only one common degree 
of freedom 𝜅. Therefore, the Equations 4.22 and 4.23 can be solved for the 5 independent microstruc-
tural parameters. The most successful parametrization used by the WMTI model is the Watson distribu-
tion as shown in the Equation 4.24 [77].   
 𝑝(?̂?) ∝ 𝑒−𝜅(𝑢.𝑛) [4.24] 
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Thus, the fiber ODF moments ℎ𝑙 are defined by 𝑝𝑙 with  l=2,4 as a function of 𝜅 and can be matched 
with the measured DWI signal. The solutions to the Equations 4.22 and 4.23 are given by the Equations 
4.25-29 with the rotational invariants of 𝐷 and K being defined by the Equations 4.30-34.  
 3𝐷0 = (1 − 𝑓)(2𝐷𝑒,⊥ + 𝐷𝑒,∥) + 𝑓𝐷𝑎 [4.25] 
 3
2
𝐷2 = 𝑝2 ((1 − 𝑓)(𝐷𝑒,∥ − 𝐷𝑒,⊥) + 𝑓𝐷𝑎) [4.26] 
 
(1 − 𝑓)(5𝐷𝑒,⊥
2 + (𝐷𝑒,∥ − 𝐷𝑒,⊥)
2
+
10
3
𝐷𝑒,⊥(𝐷𝑒,∥ − 𝐷𝑒,⊥))𝐷2
2 + 𝑓𝐷𝑎
2
= 5𝐷𝑜
2 (1 −
𝐾0
3
) 
[4.27] 
 1
2
𝐷2(𝐷2 + 7𝐷0) +
7
12
𝐾2𝐷𝑜
2
= 𝑝2 ((1 − 𝑓)((𝐷𝑒,∥ − 𝐷𝑒,⊥)
2
+
7
3
𝐷𝑒,⊥(𝐷𝑒,∥ − 𝐷𝑒,⊥)) + 𝑓𝐷𝑎
2) 
[4.28] 
 9
4
𝐷2
2 +
35
24
𝐾4𝐷𝑜
2 = 𝑝2 ((1 − 𝑓)(𝐷𝑒,∥ − 𝐷𝑒,⊥)
2
+ 𝑓𝐷𝑎
2) [4.29] 
 
 
𝐷0 =
2𝑅𝐷 + 𝐴𝐷
3
= 𝑀𝐷 [4.30] 
 
𝐷2 =
2
3
(𝐴𝐷 − 𝑅𝐷) [4.31] 
 𝐾0 = 𝑀𝐾 [4.32] 
 
𝐾2 =
1
7
(3𝐴𝐾 (
𝐴𝐷
𝑀𝐷
)
2
+ 5𝑀𝐾 − 8𝑅𝐾 (
𝑅𝐷
𝑀𝐷
)
2
) [4.32] 
 
𝐾4 =
4
7
(𝐴𝐾 (
𝐴𝐷
𝑀𝐷
)
2
− 3𝑀𝐾 + 2𝑅𝐾 (
𝑅𝐷
𝑀𝐷
)
2
) [4.34] 
In practical terms, the rotational invariants are estimated from the tensors and inputted into the system 
of Equations 4.25-29. The first four equations are solved analytically by expressing 𝑓 and all the diffu-
sivities in terms of 𝑝2 and then 𝜅 is determined by solving the last equation numerically, which is related 
to the orientation dispersion through the Equation 4.35, with 𝐹 being the Dawson’s function.  
 
𝑐2 =
1
2√𝜅𝐹(√𝜅)
−
1
2𝜅
 [4.35] 
Due to the squared diffusivities in the parametrization, the system of Equations 4.31-35 has two 
possible solutions [16], [80], [82]: one solution corresponds to the condition 𝐷𝑎 < 𝐷𝑒,∥ and the other 
fulfils 𝐷𝑎 < 𝐷𝑒,∥. In certain neurodegenerative pathologies, both 𝑓 and 𝐷𝑎 are expected to be lower as 
there is damage and loss of function of the tracts. 𝐷𝑒,║  and 𝐷𝑒,ꓕ characterize the degree of cellular 
crowding and might be higher in case of inflammation or as a result of demyelination. With potential 
loss of structure of the fibers, there is higher orientation dispersion and 𝑐2 is expected to be lower.  
Numerous models have been developed to alleviate the downsides of both NODDI and WMTI-Wat-
son, although they come with the expense of new parameters. The intrinsic assumptions of each model 
have the potential to introduce bias in the estimation of diffusion properties, but nevertheless all models 
indeed outperform DTI and DKI in capturing specificity and bringing new interpretations of the under-
lying changes of diffusivity. The choice of the model to use should have into account the purpose of the 
analysis since the reliability in pathological tissue needs further investigation [17].         
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2.3.5. Tractography 
Assuming that the orientation of the largest component of the diagonalized diffusion tensor corre-
sponds to the orientation of dominant axonal tracts in a certain voxel, DTI can provide a 3D vector field 
with each component representing the fiber orientation. Based on this information, it is possible to re-
construct a 3D trajectory, method referred to as tractography. Particularly, the study of white matter has 
been making progress due to tract reconstruction methods since there is a coherent fiber orientation 
within a voxel. On the contrary, isotropic gray matter anisotropy information is dominated by random 
noise, and therefore a single gray matter voxel may have incoherent fiber orientation. 
Tractography can be performed using either deterministic or a probabilistic approaches. [83]. The 
most intuitive way to reconstruct a 3D trajectory from a field of fiber orientations is to propagate a line 
from a seed point by following the local fiber orientation at each iteration. This is the conceptual idea 
of deterministic approaches, also known as propagation methods, and based on which several streamline 
tracking techniques have been proposed over the years. In detail, seeds are placed in voxels with FA 
greater than a certain threshold to only include white matter voxels (𝐹𝐴 ≈ 0.5). These seeds grow in 
both directions along the dominant diffusion direction, generating streamlines according to the dominant 
diffusion direction in the neighbouring voxel. A streamline is terminated when it reaches a voxel with 
sub-threshold FA or when the turning angle exceeds a certain limit.  
The first successful tractography obtained was the “connect-the-voxels” approach [84]. As voxels 
are discrete entities, the vector information contained in each voxel was not being fully reflected in the 
propagation. To overcome this issue, the vector field was turned into a continuous number field, so that 
the streamline could be continuously propagated rather than discretized in such a way that a streamline 
exits a pixel to enter the next one at a location with continuous coordinates [85]. This method is called 
FACT (Fiber Assignment by Continuous Tracking). Since FACT still lacked streamline smoothness, 
tensor interpolation was proposed by a continuous non-linear method [75] in which the principal diffu-
sion direction was treated as the path tangent. These methods are depicted in the Figure 2.13. 
 
 
Figure 2.13: Deterministic tractography methods. A) discretized “connect-the-voxels”. B) continuous FACT. C) non-linear 
method [83]. 
 
Such deterministic methods are, however, susceptible to noise accumulation as the propagation of 
streamlines becomes longer. Although the noise effect can be reduced using smoothing, it comes with a 
cost in the reduction of data resolution and slows down the computation. At the millimeter scale resolu-
tion typical of DTI, the widespread divergence and convergence of white matter fascicle lead to a con-
siderable amount of intra-voxel orientational heterogeneity. At the low b-values conventionally em-
ployed by DTI, the diffusion tensor possesses only a single orientational maxima that is its major eigen-
value. This makes it incapable of capturing intra-voxel orientational heterogeneity in the form of cross-
ing fibers, branching issues and partial volume effect [83].  
An assessment of all drawbacks of deterministic methods led to a turnaround into a probabilistic 
perspective of fiber reconstruction, in which a fiber orientation distribution probability function is ob-
tained at each voxel and a streamline follows a particular path according to its likelihood [86], [87]. This 
is possible as long as diffusion signals can be detected with multiple discrete maxima indicating the 
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presence of multiple underlying fiber population. High-angular resolution, i.e. high b-value diffusion 
direction sampling, is therefore required in diffusion data acquisition for probabilistic tractography, as 
models can provide more information than the DTI-based tractography. In this way, not only this method 
takes into account the uncertainty of fiber orientation allowing for multiple paths, it is also more robust 
to noise in the sense that streamlines along noisy paths are of low probability and tend to disperse. As a 
result, the importance of curvature and anisotropy stopping criteria is reduced.  
One of the most popular models for fiber ODF estimation is the use of spherical deconvolution [88].  
In this model, the diffusion signal characteristic of each fiber population is assumed to be identical in 
all respects apart from their orientation. Hence, the response function from a single coherently oriented 
fiber population is represented as 𝑅(𝜃), being 𝜃 the elevation angle in spherical coordinates, relative to 
the z-axis. Considering that the diffusion signal emanating from different regions add independently to 
generate the total signal measured, this signal is given by the sum of the response functions, weighted 
by their respective volume fractions 𝑓𝑖 and with a certain rotation onto the direction (𝜃, 𝜙) represented 
by the operator 𝐴?̂?, as shown in the Equation 4.36 [88].  
 
𝑆(𝜃, 𝜙) = ∑𝑓𝑖
𝑖
𝑅(𝜃)𝐴?̂? [4.36] 
The fraction of fibers aligned along the direction (𝜃, 𝜙) is, in fact, its orientation density. The fiber 
orientation density is in fact the fiber ODF 𝜓(𝜃, 𝜙) and thus, differences in the ODF amplitude along a 
given orientation can be attributed to differences in the relative amount of fibers thought to be aligned 
with that direction [87]. Hence, the total signal measured can be expressed as the convolution of the 
response function with the fiber ODF along the direction (𝜃, 𝜙), as shown in the Figure 2.14 and given 
by the Equation 4.37. The response function can be estimated directly from data by measuring the dif-
fusion-weighted signal profile in regions likely to contain an oriented fiber population, i.e. where the 
diffusion anisotropy is higher [88], [89].  
If the response function is known a priori, the ODF can be obtained by performing the spherical 
deconvolution of 𝑅(𝜃) from 𝑆(𝜃, 𝜙). Spherical deconvolution uses a set of spherical and rotational har-
monics [90] and can be formulated as the action of an ensemble of rotations corresponding to the con-
volution kernel. Therefore, it can be simplified into a set of matrix multiplications through a simple 
linear least squares fit. 
 𝑆(𝜃, 𝜙) = 𝑅(𝜃) ∗ 𝐹(𝜃, 𝜙) [4.37] 
 
 
Figure 2.14: Fiber populations within a voxel with orientations (θ1,ϕ1) and (θ2, ϕ2). The measured signal can be obtained by 
the convolution between the response functionl and the fiber ODF [88]. 
 
A potential application of spherical deconvolution of the diffusion signal obtained from high-angular 
resolution diffusion-weighted acquisition is to reliably reconstruct tracts in regions of crossing fibers. A 
successful metric proposed for voxel-wise comparison of tracts is the apparent fiber density (AFD). It 
reflects the relative amount of underlying axons thought to be aligned with a certain orientation in each 
voxel [91], grounded on information provided by the ODF.     
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2.4. DWI image processing 
2.4.1. General image noise correction 
Microstructural modelling sets a high bar on estimating signals in an unbiased way, considering that 
the non-Gaussian random nature of noise is very likely to bias diffusion parameters, as confirmed by the 
low SNR typical of diffusion data [92]. The correction of this noise-induced bias relies on an independ-
ent unbiased estimate for the noise map, that can denoise the original data. Most of the existing noise 
estimation methods that are able to deal with spatially varying noise patterns depend on many unrealistic 
assumptions such as homogeneous signal intensities. Recently, a new model-independent approach was 
proposed [93] based on the Random Matrix Theory. . 
 The elements of a random matrix are random variables from several probability distributions. The 
main goal of this method is to provide understanding of the diverse properties of the matrix after de-
composition into its linearly independent sources with Principal Component Analysis. Since DWI data 
are said to exhibit redundancy, an uncorrelated basis set can be extracted as an independent source from 
the random matrix and characterized as noise [93]. Thus, by coupling Random Matrix Theory with 
Principal Component Analysis, the precise estimation of local noise in multi-directional data is possible.  
This random type of noise however does not include subject motion or other physiological variations 
such as the breathing and the heart rates. Naturally, such periodic variations cannot be assessed with 
random noise approaches. One strategy to deal with it is to apply an automatic detector of outliers in the 
data, exclude them and refit the model without the presence of these outliers. This method is called 
robust model fitting and the most common algorithm is the RESTORE algorithm [94], which uses an 
iterative reweighted process with Monte Carlo simulations to find the outliers. 
 
2.4.2. Image correction in EPI acquisition 
Single-shot EPI is the most widely used DWI acquisition method because it is fast, efficient and 
insensitive to small motion [95]. As mentioned in the Section 2.2.4, the fast acquisition speed of EPI 
effectively freezes any head motion, maximizing the image SNR and the accuracy of diffusion meas-
urements. Although EPI is available in most clinical MR systems, its use has certain disadvantages. 
First, the mechanical impacts on the holder (tilting) occur as a result of the gradients changing rapidly, 
causing vibration of the system. Moreover, according to Faraday’s law of induction, a changing mag-
netic field in a conductor creates the so-called eddy-currents. When these gradients are applied, the eddy-
currents account for distortions in the image, causing misalignments that lead to errors in the estimation 
of diffusion maps [96]. The images may be further warped non-linearly due to magnetic field inhomo-
geneities caused by non-zero off-resonance fields induced by the susceptibility field of the tissue [97]. 
The homogeneity level might be determined by the linewidth of the spectrum of frequencies.  
All things considered, diffusion EPI images are particularly vulnerable to distortion and sources of 
misregistration from a combination of eddy-currents, motion and magnetic field inhomogeneities. Ide-
ally, these should be corrected before calculating any subsequent quantitative diffusion maps. Image 
distortions can be reduced using bipolar diffusion-weighting schemes [98], correction with the displace-
ment field [99], or image registration methods [96], which are mentioned in the Section 2.4.4. Bipolar 
diffusion-weighting schemes use two diffusion-encoding gradients with opposing polarities between the 
90º and the 180º RF pulses. Both gradients induce eddy-currents that cancel out because they are inverse. 
As this option requires a higher TE, an alternative is to acquire an image with each of these gradients at 
a time. The displacement field can be calculated because distortion is imaged in opposing directions and 
used to correct the original image. As mentioned previously, sequence parameters selection such as 
increasing the number of encoding directions or the SNR improve the accuracy of DTI measures. Un-
fortunately, these increase the scan time and increase the partial volume effect respectively.  
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2.4.3. Bias field correction 
One of the concerns during image processing is an undesirable low-frequency signal designated bias 
field that is caused by magnetic field inhomogeneities of MRI machines. This smooth signal corrupts 
the high-frequency content of images, blurring its edges. In addition, it changes the intensity values of 
image pixels, causing one single tissue to have different gray-level distributions across the image.  
Applying high-pass filters was one of the first methods for correcting the bias field. Recently, ap-
proaches towards the elimination of contrast differences and the maximization of high frequency content 
include the expectation maximization algorithm. It divides one function that has multiple local maxima 
into a sequence of subfunctions each with global maxima. Thereby, this tool is applied to segmentation 
algorithms in order to find the most likely location of tissues and then correct for the bias field induced 
spatial invariance with a smoothing kernel. 
 
2.4.4. Image registration 
The aim of neuroimaging in longitudinal studies is to consistently and accurately communicate the 
spatial relationship within data and thus compare data across subjects, time, image types or other con-
ditions, classify data in terms of meaningful position-dependent metrics and find patterns. These benefits 
are contingent on the premise that positions and sizes in one brain must correspond to positions and 
sizes in another brain. Determining anatomical correspondence is almost universally done by image 
registration, in which brains are transformed into one another or into a template. The essential compo-
nents of any generic registration algorithm are transformation models, similarity measures and optimi-
zation strategies. These steps combined lead to image spatial normalization while finding the optimal 
transformation that maps each x of the image 𝐼(𝑥) to a location z in the image 𝐽(𝑧), such that a specified 
cost function 𝐷(𝐼, 𝐽), that describes the similarity between 𝐼 and 𝐽, is minimized [100].  
Registration algorithms can be divided into linear and non-linear, depending on the type of defor-
mations they permit. Linear registration includes transformation models capable of performing transla-
tion, scaling, rotation and shearing. With up to 12 degrees of freedom (DOF), linear transformations 
globally deform an image, while preserving collinearity and ratios of distance. Particular cases of linear 
transformation are the 6-DOF rigid-body transformation widely used in data from the same subject or 
affine transformation that uses 12 DOF. With over 12 DOF, non-linear registration matches boundaries 
and internal structures by warping the data and allows for the local alignment between two images.  
Transformations are carried out by a simple multiplication matrix of the voxels coordinates from one 
image to give the corresponding coordinates of another. If a voxel at coordinates 𝑥𝑖 undergoes a trans-
formation to the coordinates 𝑧𝑗, the mapping of the deformation is given by the Equation 4.38. 
 
𝑧𝑗 = ∑𝑚𝑗𝑖𝑥𝑖
3
𝑖=0
+ 𝐶𝑗 [4.38] 
In this notation, 𝑚𝑖𝑗  with 𝑖, 𝑗 = 1,2,3 specifies the respective transformation matrix. This matrix 
𝑚𝑖𝑗 = 𝑀𝑟 is such that 𝑀𝐼
−1𝑀𝑟𝑀𝐽 will co-register the images 𝐼 and 𝐽 and define the transformation that 
maps the space of 𝐼(𝑥) to that of 𝐽(𝑧) [101], [102]. An additional matrix 𝑀𝑋 should account for image 
dimensions, since its voxels might be anisotropic and often differ from other images. Thus, using a given 
interpolation method, the image is resampled according to its FOV and axis size as in the Equation 4.39.  
 
𝑀𝑋 = [
𝐹𝑂𝑉𝑥 0 0 𝑆𝑖𝑧𝑒𝑥
0 𝐹𝑂𝑉𝑦 0 𝑆𝑖𝑧𝑒𝑦
0 0 𝐹𝑂𝑉𝑧 𝑆𝑖𝑧𝑒𝑧
0 0 0 1
] [4.39] 
 24 
 
3. Methods 
 
This project aims at studying the brain microstructure of the icv-STZ rat, since this animal model has 
shown features typical of AD, yet it has never been assessed with MRI-derived techniques. The study re-
quired MRI data acquisition and processing for posterior statistical analysis. The study design and acquisition 
are explained in the Sections 3.1 and 3.2. The existing image processing pipeline is fully described in the 
Section 3.3 and it was primarily used to obtain preliminary results and come up with a methodology to im-
prove it. The improvement strategies are described in the Section 3.4 and the statistical analysis is described 
in the Section 3.5. The strategies for additional approaches to analyse the available diffusion data are shown 
in the Section 3.6.  
 
3.1. Study design 
The longitudinal study of the brain microstructure in the icv-STZ rat required two study groups for 
comparison. Therefore, a treated (STZ) and a healthy or control (CTL) groups took part in the study and 
underwent an icv-injection so that all rats were under the same conditions.  
The CTL group (241±23 g at injection, N=8) was injected with a citrate buffer, while the STZ group 
(245±17 g at injection, N=10) was injected with 3 mg/kg of streptozotocin. As shown in the Figure 3.1, 
each rat was scanned at four time points after injection following the ethics plan of the local Service for 
the Veterinary Affairs. MRI data were collected at 2, 6, 13 and 21 weeks after injection and rats were 
subsequently sacrificed by perfusion fixation under sedation. This euthanasia method was used to enable 
brain extraction and acquire histological data to support imaging results in future projects. 
 
 
Figure 3.1: Experimental timeline of the longitudinal study.  
 
3.2. MRI data acquisition 
According to the Figure 3.1, each rat underwent four sessions of MRI scans. Before each scanning 
session, rats were exposed to isoflurane, which is an anaesthetic administrated by inhalation. After se-
dation, rats were tightly fixated in a holder according to a very precise experimental setup while vital 
signs including body temperature and breathing rate were being monitored. A surface coil was placed 
over the head and close to the skin, in such a way that the whole brain could be captured on image. The 
holder was finally slided into a 14 T Varian system and the resonance frequency of the coil was fine-
tuned to 600 MHz. The experimental setup is shown in the Figure 3.2.       
Moreover, the power of the RF pulses was calibrated to obtain a 90° excitation pulse at the desire 
depth from the brain surface, and the magnetic field was adjusted to be as homogeneous as possible, 
especially around the regions of interest (ROIs) of the study. The optimization of field homogeneity is 
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called shimming and it consists in changing electric currents that create new magnetic fields that when 
summed up with B0 make the total magnetic field homogeneous in each direction. The shimming algo-
rithm was performed in three steps, in which more directions were evaluated consecutively, so that the 
susceptibility distribution could be compensated for. Shimming was repeated whenever rats might have 
undergone vibration and moved from the original location, as often occurs in EPI acquisitions.  
 
 
Figure 3.2: Experimental setup for the MRI scan. A) rat holder. B) capacitors for adjustment of frequency by tuning and 
matching procedure. C) superficial rat head coil. D) water tubes for body temperature adjustment. E) sedation injection. F) 
anal thermometer. G) breathing sensor. 
 
Each scanning session comprised three acquisition protocols to obtain anatomical, diffusion and rest-
ing-state functional MRI (rs-fMRI) images. Diffusion assessment was the primary focus of this project, 
while rs-fMRI data was processed and analysed within the ambit of another project. The outcomes of 
that analysis are briefly elucidated in the Chapter 5 as they support microstructural results.  
The anatomical images were T2-weighted and since they were only used for spatial localization and 
not quantitative purposes, the scanning time was reduced by using a fast spin-echo sequence, with 
𝑇𝐸/𝑇𝑅 = 10.17/3000  ms, 𝑚𝑎𝑡𝑟𝑖𝑥 = 128𝑥128 , 𝐹𝑂𝑉 = 19.2𝑥19.2  mm3, 𝑣𝑜𝑥𝑒𝑙 𝑠𝑖𝑧𝑒 = 0.15𝑥0.15 
mm3 and 30 slices with 0.5 mm thickness.  
 The diffusion protocol was performed with a semi-adiabatic spin-echo EPI acquisition. The se-
quence included the following parameters: 𝑇𝐸/𝑇𝑅 = 48/2500  ms, 𝑚𝑎𝑡𝑟𝑖𝑥 = 128𝑥64 , 𝐹𝑂𝑉 =
23𝑥17 mm3, 𝑣𝑜𝑥𝑒𝑙 𝑠𝑖𝑧𝑒 = 0.18𝑥0.27 mm3 and 9 slices with 1 mm thickness in 𝑁𝑅 = 4 repetitions. 
Data were acquired in three different shells and a total of 62 measurements, as shown in the Figure 3.3, 
provided that at least 21 measurements with at least 2 non-zero shells were required for regression of 
tensor estimation, as explained in the Section 2.3.3. Four b= 0 ms/µm2 (b0) images, i.e. with no diffusion 
weighting, were acquired as well. Another shell with 𝑏 = 0.8 ms/µm2 was acquired in 12 directions, 
𝑏 = 1.3 ms/µm2 in 16 directions and lastly 𝑏 = 2 ms/µm2 in 30 directions.  
In order to make up for the distortions caused by eddy-currents in the processing pipeline, two short 
b0 images were acquired with opposing gradients each, linear and reverse linear. 
 
 
Figure 3.3: Plot of the b-values acquired in a total of 62 directions in one of the repetitions. 
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3.3. Existing image processing pipeline 
The existing image processing pipeline is herein described. It includes all the processing steps taken 
towards the quantification of diffusion in the white matter. Several stages were included in order to 
correct images in terms of noise and MRI-induced artefacts and to enable the comparison across datasets. 
Diffusion was assessed in four ROIs within this project by calculating diffusion and kurtosis tensors and 
estimating the WMTI-Watson model.  
 
3.3.1. Data reconstruction and brain extraction 
Anatomical and diffusion data were reconstructed automatically in the Varian system, being only 
necessary to convert them into a common file type for additional processing. Since one of the most 
conventional formats to represent neuroimaging information is the NIfTI (Neuroimaging Informatics 
Technology Initiative), the Tools for NIfTI and ANALYZE image from Matlab were used for conversion 
into .nii images. The reconstructed anatomical (A) and diffusion images are shown in the Figure 3.4, 
with the later including the images resulting from the linear (B) and reverse linear (C) acquisition direc-
tions. The differences are mainly evident at the bottom of the brain, where structures seem more com-
pressed in the linear direction and more stretched in the reverse linear. This difference allows for the 
estimation of the displacement field and distortion correction, as treated in detail in the next section.  
 
 
Figure 3.4: Reconstructed MRI images in each modality (column) in two coronal planes (rows).    
  
 Following reconstruction, a mask was created to extract only brain tissue from data to be used in the 
subsequent stages of the pipeline. Thus, brain extraction refers here to the separation between brain and 
non-brain tissue. In the initial pipeline, the brain was extracted manually from anatomical and diffusion 
data using MRIcron [103], by carefully drawing the contour of the brain and filling in the inside of the 
outline. The drawn mask (A and C) and the extracted brain (B and D) of anatomical and diffusion data 
are shown in the Figure 3.5. It is important that brain extraction precedes bias field correction and reg-
istration so that when accounting for the intensity distribution or the parcellation of the brain, external 
regions such as fat or muscle are not included. 
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Figure 3.5: Manually drawn masks of the brain and resulting extracted brains in anatomical and diffusion data in two coro-
nal planes (rows).  
 
3.3.2. dMRI data correction 
After reconstruction and brain extraction, data underwent corrections for quality improvement and 
reliability of quantitative measures. Measurement repetitions were averaged and diffusion images were 
firstly denoised using the method of the Random Matrix Theory and Principal Component Analysis 
coupling [93]. A data matrix with Marchenko Pascur distribution was generated and Principal Compo-
nent Analysis eigenvalues were computed in the extracted brain. Each image was then associated to a 
noise map, SNR map and the denoised version of the brain.  
After random noise minimization, specific EPI distortions were minimized as well. The topup func-
tion of FSL estimated the susceptibility field by finding when the similarity of the unwarped images was 
maximal, using the sum-of-squared differences [104]. Therefore, linear and reverse linear acquisition 
directions datasets were used to correct the displacement distortions of the main image caused by mag-
netic field inhomogeneities. In the same context, the eddy tool from FSL [105] was helpful as it separated 
the offset eddy-current field from motion and aligned the different weighted images. A comparison be-
tween the original unedited diffusion data (A), denoised (B) and distortion corrected data (C) is shown 
in the Figure 3.6. From A) to B) the correction of random noise is evident with the denoised image being 
“cleaner” and with brain structures better delineated. From B) to C), differences are clear in terms of the 
ringing that was induced by motion and non-brain tissue is entirely removed from data at this stage. 
 
 
Figure 3.6: Sequential steps of diffusion data correction in two coronal planes (rows).  
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3.3.3. Spatial normalization of anatomical MRI data for co-registration 
In this project, anatomical data were acquired merely to provide spatial information of brain struc-
tures in the diffusion space, rather than to perform any morphometric analysis. A robust concept of 
location was required so that explicit estimation of diffusion measures could be done over certain regions 
of the brain known to be affected in AD and can be compared across datasets, between study groups and 
time points. Hence, anatomical images were registered to a template so that diffusion and anatomical 
data could be posteriorly co-registered.  
Instead of creating a template by averaging anatomical data, an available high-field MRI unbiased 
standard space template image, designated Waxholm Space (WHS) [106] was used to align anatomical 
datasets to. An available 255-tissue segmented atlas provided by the Minimal Deformation Template 
(MDT) [107] was transformed into the same space to be further used as the parcellation template of the 
rat brain. The template anatomical image A) and atlas B) are shown in the Figure 3.7. 
 
 
Figure 3.7: WHS template space where anatomical data were registered to. 
 
All anatomical datasets were aligned to the anatomical template using affine transformation followed 
by higher DOF non-linear registration (𝑇𝐴2𝑇), so that non-localized rotation, translation and scaling oc-
curred, as well as local warping. FSL tools were used in this regard, such as FLIRT (FMRIB’s Linear 
Registration Tool) [108], [109] and FNIRT (FMRIB’s Non-linear Registration Tool) [110]. Affine reg-
istration was estimated with the mutual information cost function, 12 DOF and trilinear interpolation; 
whereas non-linear registration used with the affine transformation matrix as the starting estimate for 
initial alignment, warp resolution of 1 mm in all directions, a cubic spline, a smoothing Gaussian kernel, 
a non-linear model for intensity mapping, 5 iterations in each direction and a final linear interpolation.     
The purpose of registration in this pipeline was not to align all datasets in the same stereotaxic space, 
but to align the template atlas in each single dataset space and obtain brain parcellation. The inverse 
warping matrix (𝑇𝐴2𝑇
−1 = 𝑇𝑇2𝐴) of the non-rigid registration was calculated, allowing for the transfor-
mation of the template space into the anatomical space of each dataset, using the FSL function invwarp.   
 
3.3.4. dMRI data registration and segmentation 
In order to obtain an atlas aligned to diffusion data, each diffusion dataset was transformed into the 
respective anatomical data space (𝑇𝐷2𝐴) using the same affine parameters aforementioned. The function 
convert-xfm from FSL allowed for the estimation of the inverse transformation matrix (𝑇𝐷2𝐴
−1 = 𝑇𝐴2𝐷), 
which was further convoluted with the inverse warping matrix previously estimated (𝑇𝑇2𝐴). This oper-
ation was performed by the FSL function applywarp using the nearest neighbour method to interpolate 
the integer values of the atlas, finally obtaining a map in the diffusion space of each dataset. The regis-
tration methodology aforementioned is shown in the Figure 3.8. 
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Figure 3.8: Schematic representation of the registration procedure. Anatomical data in A) was registered into the template 
image B) so that the deformation field from the template space to the original anatomical space could be calculated. Diffu-
sion data in D) and anatomical data in A) were co-registered so that the deformation field from the anatomical space to the 
diffusion space could be calculated. Finally, the transformations from the template space to the anatomical space and from 
this to the diffusion space were convoluted in order to calculate the transformation of the atlas in the template space C) to the 
diffusion space and obtain an atlas E) for each diffusion dataset. 
 
From the diffusion-transformed atlas, white matter regions known to be involved in AD, according 
to previous findings in human studies [35], [57] and in the icv-STZ animal models [8]–[10], [12], [20] 
were extracted. The tracts selected to characterize white matter were the corpus callosum, the cingulum, 
the fimbria and the fornix and each one was transformed into a binary mask such that diffusion param-
eters were estimated specifically in these ROIs. Tracts are represented in the Figure 3.9. 
 
 
Figure 3.9: White matter ROIs in different coronal planes (columns).  In A) ROIs are represented as binary labels and B) is 
the original diffusion data where labels are overlapped.  
 
 30 
 
3.3.5. Diffusion and kurtosis tensors estimation 
Following denoising and distortion correction, unbiased diffusion data were used to estimate tensors 
and its measures using Matlab. First, the b-matrix initially extracted from the acquisition parameters 
was loaded and DTI was estimated with the weighted linear least squares estimator, according to the 
simplified cumulant expansion Equation 4.9 [111]. The eigenvalue decomposition was performed be-
cause the metrics chosen for this study were invariant metrics of diffusion [23]. Thus, the metrics MD, 
AxD, RD and FA were calculated in each voxel from the Equations 4.12-15, respectively.  
In non-Gaussian DKI, the cumulant expansion was used without any prior assumptions (Equation 
4.8) and the kurtosis tensor was obtained using the same estimator [111], where the several diffusion 
shells and multiple directions allowed the fitting of the tensors [70], [71]. The metrics MK, AK and RK 
from the Equations 4.16-18, respectively, were calculated in each voxel to complement DTI information 
[14]. Therefore, DTI and DKI estimation provided altogether seven parametric maps of the whole brain 
shown in the Figure 3.10, where different contrasts result from the way scalar values are calculated from 
the tensors and thereby provide different information.  
 
 
Figure 3.10: Parametric maps of DTI and DKI quantitative metrics.  
 
Tensor models take into account certain types of noise such as thermal noise or magnetic field inho-
mogeneities, but not others, such as physiological noise that is seen as motion inside the scanner. Since 
EPI acquisitions have such high sensitivity to motion, an automatic detector of outliers was used to 
refitting the model estimation, so that the effects of the breathing and the heart rates present in data were 
excluded from the estimation. The RESTORE algorithm [94] was used and the noise map previously 
obtained in the denoising phase was provided for the initial iteration of the reweighted process. The 
outlier voxels were therefore removed subsequently from the fit in an attempt to remove artefacts that 
were not removed earlier in the processing pipeline. 
In order to avoid potential outranged values in these parametric maps, a filter was applied before 
statistical analysis. Unphysical values were caused by artefacts unable to be removed from data and 
more importantly by partial volume effect. When a voxel labelled as white matter was capturing regions 
of the gray matter or CSF it caused, for instance, MD to be much higher, because those are isotropic 
regions. This issue is further addressed in the Section 3.4.4. Considering this, the filtering condition 
consisted in only including in the analysis voxels with values within the expression in the Equation 5.1. 
All these conditions characterize white matter in terms of scalar values. 
 𝐹𝑊𝑀: 0 < 𝑅𝐾 < 10 ∧  0 < 𝑀𝐷 < 2.5 ∧  0 < 𝑀𝐾 < 2 [5.1] 
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3.3.6. Estimation of the WMTI-Watson biophysical model of the white matter 
As to provide specificity to the diffusion analysis, a model of the white matter was estimated and 
yielded complementary measures [17]. The WMTI-Watson model is one of the most well-established 
existing models at the moment because it relies on DTI and DKI measures and does not depend on 
unstable non-linear fitting of parameters [16], [77]. Therefore, WMTI-Watson was estimated on Matlab, 
where tensors metrics were loaded to further calculate the rotational invariants of 𝐷 and 𝐾 as given by 
the Equations 4.30-34. The solutions were obtained with the Equations 4.25-29 using the Matlab tool 
fsolve, that was fed with 𝐷0, 𝐷2, 𝐾0, 𝐾2 and 𝐾4, the option of 5000 iterations and an initial guess of 
parameters 𝑥0 = [𝑓0, 𝐷𝑎0, 𝐷𝑒,║0
, 𝐷𝑒,ꓕ0, 𝜅0] = [0.35, 2.5, 0.85, 0.75, 5].  
Its output was then the series of five parameters 𝑓, 𝐷𝑎, 𝐷𝑒,║, 𝐷𝑒,ꓕ and 𝜅, and 𝑐2 was calculated using 
the Equation 4.35. The mathematical solution 𝐷𝑎 > 𝐷𝑒,∥ was here retained based on recent evidence 
[82]. Since fsolve solves systems of non-linear equations with several variables, it is extremely time-
consuming. To reduce the amount of time spent to obtain these parametric maps, the system was not 
solved over the whole brain data, but only over the ROIs. The parametric maps obtained after model 
computation are shown in the Figure 3.11, where scalar values are only given for ROIs. 
 
 
Figure 3.11: Parametric maps of parameters resulting from the WMTI-Watson model in two coronal planes (rows).  
 
Due to the risk of divergence of parameters during the fitting, a filter was applied to the 5 parametric 
maps provided by the WMTI-Watson model. Voxels were only kept for statistical analysis under the 
condition stated by the Equation 5.2. It forced all voxels to have a set of parameters within a biophysical 
acceptable range of values. An example of a filtered map is the Figure 3.12 and shows that a great deal 
of voxels is clearly outside of the range of vales required. This issue is addressed in the Section 3.4.5. 
 
𝐹𝑊𝑀𝑇𝐼: 0 < 𝑓 < 1 ∧  1 < 𝐷𝑎 < 3 ∧  0 < 𝐷𝑒,║ < 3 ∧  0 < 𝐷𝑒,ꓕ < 3 ∧  
1
3
< 𝑐2 < 1 [5.2] 
 
 
Figure 3.12: Parametric maps of f before (A) and after the filter FWMTI is applied (B) in two coronal planes (rows).  
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3.4. Optimization strategies to the existing pipeline 
The improvements proposed to the existing processing pipeline are herein described. To understand 
how to optimize the pipeline, preliminary results were obtained in the first part of the traineeship using 
the methodology described in the Section 3.3. From speeding up some stages of the existing pipeline to 
improve data quality, subprojects were developed in the second part of the project. Each of the subse-
quent sections is one optimization strategy, whose results are shown in the Section 4.1. If these results 
were satisfactory, strategies were implemented in the existing pipeline and the statistical analysis was 
computed considering the adjustments made.  
 
3.4.1. Improvement of white matter labels in the template atlas 
The existing 255-label 300-slice template atlas was initially developed for gray matter analysis and 
white matter tracts were not quite properly represented. Namely, the external capsule, corpus callosum 
and cingulum were represented as a single tissue, structures in general were not fitting in with each other 
with several voxels having the value “0”, some of the labels did not match exactly the tissue in the 
underlying anatomical image and some of them were missing. Since the aim of this project is to assess 
the white matter microstructure, additional care was taken with image-label correspondence.  
Therefore, the methodology to improve the existing template atlas in terms of white matter regions 
consisted in manually redrawing these structures slice-by-slice when overlaid onto the anatomical tem-
plate image using ITK-SNAP [112]. This hands-on methodology was based on the extensive information 
collected from the Data Portal of the Allen Brain Atlas ©. In this way, there would be less partial volume 
effect and diffusion metrics in each ROI would be more reliable. The differences between the original 
and the latest version of the improved atlas were evidenced by subtracting one from the other using 
ImageJ.  
 
3.4.2. Semi-automatic brain extraction 
Manual brain extraction was one of the most time-consuming steps in the pipeline considering that, 
for each dataset, a brain mask was drawn in 30 anatomical slices and 9 diffusion slices. Since over 45 
datasets were to be processed in the course of this project, finding a solution for this issue was naturally 
one of the first concerns. The most obvious solution consisted in the automatization of the process using 
specific algorithms for brain extraction that usually generate meshes to model the brain surface. While 
there are several tools for extracting the human brain, only few of them apply to rodents. Three tools 
were considered to meet the requirements to be used in this pipeline and replace manual work: the bet2 
(brain extraction tool) from FSL and the 3dSkullStrip and 3dAutomask from AFNI (Analysis of Func-
tional NeuroImages). Since only the latter is suitable for EPI data, bet2 and 3dSkullStrip were tested in 
anatomical data, whereas 3dAutomask was tested in diffusion data as follows. 
Bet2 generated a binary brain mask by iteratively expanding and deforming its initial tessellated 
mesh until enveloping completely the brain, according to several dynamic controlling parameters [113]. 
In turn, AFNI’s 3dSkullStrip [114] was adapted from bet2 and included a new set of processing opera-
tions more specific anatomical-wise. The expansion of the spherical surface was improved by a 3D edge 
detection tool, tools to avoid clipping of frontal areas and to reduce leakage into the skull and the ad-
justment of features to rat data. Choosing between both tools was solved essentially by trial and error. 
First, each tool was applied to an anatomical dataset with the default settings. After trying different 
controlling parameters, neither of the two tools appeared to be sufficiently good. In the end, the best 
combination of parameters was achieved with the application of the 3dSkullStrip followed by intensity 
normalization. The tool was set up with 250 iterations, defining the mesh density, an intensity threshold 
of 0.1 and nearest neighbour interpolation followed by final smoothing using the Taubin’s method.  
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Concerning diffusion data, the advantage of the 3dAutomask from AFNI of accepting 4D (3D+time) 
EPI data compromised its robustness by not generating an iteratively expanded mesh. Instead, the largest 
components of the supra-threshold voxels were kept after erosion-dilation procedures. The intensity 
threshold in 3dAutomask was brain size-dependent and varied between 0.4 and 0.65. A dilation step 
was applied afterwards with a 3D kernel of a 3x3x3 box centered on the target voxel to compensate for 
the intensity drop at the bottom of the brain. In consequence, the dilation was equally applied on top of 
the brain, which is closer to non-brain tissues, possibly overlapping fat or muscle tissue. To understand 
how impactful overlapping could be, metrics were computed after following the entire processing pipe-
line described in the Section 3.3 using an unsupervised dilated mask in one dataset. The parametric maps 
were visually compared with the ones obtained with the manually drawn mask.  
 
3.4.3. Bias field correction 
Before registration, it is a common procedure to remove the bias field signal and uniformize the 
intensity distribution across the image that has suffered variations induced by MRI inhomogeneities 
during the scan. Here, the use of a surface coil induced a gradient in the signal’s amplitude of images 
that was a function of depth from the coil placed above the cortex. It explains the brighter signal in 
regions closer to the coil and the darker signal in regions further. By correcting the induced-bias, the 
subsequent steps are not affected by corrupted voxel values.  
Since the correction of the bias field in anatomical data was not included in the pipeline, it was one 
of the optimization strategies. Bias field correction was performed after brain extraction, because other-
wise the algorithm would account for other tissues to normalize the overall intensity. It was performed 
by the FSL tool FAST (FMRIB’s Automated Segmentation Tool) that uses a hidden Markov random 
field associated to the expectation maximization algorithm [115]. Visual evaluation was carried out.  
 
3.4.4. FA atlas-based registration of dMRI data 
In neurodegenerative diseases there is frequently enlargement of the brain ventricles over time, even 
though the nature of this process remains unclear. On the one hand, inflammation could cause the ob-
struction of the intraventricular foramen, which allows the CSF to reach the brain ventricular system, 
and the gradual reduction of CSF drainage. On another hand, the degeneration of hypothalamic cells 
could result in the caving in of tissue, leading to the taking over of CSF over the free space left [10].  
In consequence, it is common to be faced with a disease group with greater ventricle sizes than the 
CTL group, which constitutes a problem in terms of registration because regions around the ventricles 
of the disease group are shifted uncontrollably [116]. This issue affected this project and caused ROIs 
to be misaligned in the diffusion data. The registration approach failed to spatially normalize the struc-
tures around the oversized ventricles, especially the fimbria, as can be seen in the Figure 3.13.  
Misalignment naturally affected diffusion metrics because the tissue-label correspondence was no 
longer accurate. For instance, considering that water diffusion within the ventricles is isotropic, FA is 
much lower in the ventricles (FA≈0.1) than in the white matter tracts (FA≈0.5). Thus, partial volume 
effect of white matter tracts with CSF would have a lower average FA and generally a suboptimal sen-
sitivity to true differences in tensors. Accordingly, preliminary results showed that partial volume effect 
was reflected as group differences in FA in the fimbria unlikely to correspond to true differences. 
Several studies have in that regard tried to find ways to guarantee that registration was successful 
both in resolving topology variability and exact alignment of the very fine structures. Although manual 
edition of atlas labels is a helpful approach in particular situations, an automatic solution must be 
achieved for larger amounts of data in order to be an unbiased, efficient and low time-consuming pro-
cess. Approaches including affine alignment of DTI maps across datasets [117], extreme DOF non-
linear registration [118] or tractography-based registration [119] have been proposed, but failed. 
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Figure 3.13: Comparison between STZ (A) and CTL (B) rat brain ventricles at 13 weeks after injection in different coronal 
planes (columns). 
  
A newly attempt to overcome all these flawed approaches is called tract-based spatial statistics 
(TBSS) [120]. It aims to solve the alignment and smoothing issues, while being fully automated and 
without requiring pre-specifications of tracts of interest. This is achieved by projecting the FA map from 
each dataset onto a mean FA skeleton in such a way that each skeleton voxel takes the FA value from 
the nearest relevant tract center. FA was proposed because it is computable voxel-wise and a vastly used 
marker for tract integrity with scalar values independent of the local fiber orientation [118] 
In this project it was not reliable to create a skeletonized mean FA, since in this longitudinal study, 
ventricles become larger over time. Hence, an FA template image was used instead. An FA template 
was available in the template WHS, i.e. the same stereotaxic space as the template atlas [106]. Taking 
into consideration the TBSS method, FA data was registered into the FA template, replacing the con-
ventional anatomical registration described in the Figure 3.8 in the Section 3.3.4. The inverse transfor-
mation was calculated and co-registration between diffusion and with FA data was carried out, so that 
the template atlas was transformed into each diffusion dataset space. Naturally, this diffusion-trans-
formed atlas was different than the one obtained after anatomical registration, because the dataset/tem-
plate image correspondence of FA data and anatomical data is also different. 
While FA reveals differences across space, it does not reflect any information regarding direction. 
On the contrary, CCFA maps are direction-dependent as they visualize each x (CCFAx), y (CCFAy) 
and z (CCFAz) diffusion directions separately by reading the coordinates of the largest eigenvalue. 
Hence, the procedure described above was also tested with a CCFA template image and CCFA data in 
each direction. The different template images are shown in the Figure 3.14 and compared to the respec-
tive corrected diffusion parametric maps.  
 
 
Figure 3.14: Different parametric maps (columns) obtained from the pipeline (upper row) and the respective images availa-
ble in WHS template space (lower row). 
 35 
 
 
In order to evaluate the best registration procedure, a quality measure was defined. Since the outcome 
of registration in this project was the labelled atlas, the best way to quantify the misalignment of each 
procedure was to calculate the tensors metrics over the ROIs extracted from those atlases and apply the 
white matter filter FWM given by the Equation 5.1. The ratio R between the number of voxels filtered by 
the white matter cut-off and the total number of voxels of each ROI partially determines how much the 
white matter label is aligned to the underlying tissue, since the filter excludes voxels that contain CSF.   
This ratio is given by the Equation 5.3 and the higher it is, the less voxels are being excluded from 
image analysis and the less voxels are overlapping the ventricles. However this ratio does not quantify 
partial volume effect with gray matter regions. During registration, while different transformations try 
to push away the labels from the ventricles, they might force such distortions that the labels end up being 
pulled into the gray matter, which is concerning as well. Since it was too restrictive to narrow down the 
values of the diffusion metrics to exclude gray matter, visual inspection was always required.     
 
𝑅 =
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑣𝑜𝑥𝑒𝑙𝑠 𝑘𝑒𝑝𝑡 𝑎𝑓𝑡𝑒𝑟 𝐹𝑊𝑀
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑣𝑜𝑥𝑒𝑙𝑠
 [5.3] 
In a total of 30 (14 CTL and 16 STZ) datasets, linear and non-linear registration between FA, CCFAx, 
CCFAy and CCFAz data was performed. Diffusion metrics were calculated over the ROI labels ex-
tracted from each resulting atlas and finally, R was estimated for each ROI in each dataset. It was aver-
aged in CTL and STZ groups for each registration procedure and compared between each other and with 
the conventional anatomical registration procedure. Statistical analysis of the diffusion metrics was com-
puted using the labels resultant from the best method chosen for each ROI, using the statistical tests 
described in the following Section 3.5 where p-values were compared. The ultimate goal was to under-
stand whether alignment of tissue-label correspondence was significantly impactful for data analysis. If 
existing significant differences between and within groups were improved to a more powerful statistical 
significance (lower p-values), the misalignment caused by oversized ventricles would be minimized and 
the respective registration procedure would be integrated into the pipeline to obtain the final results.  
 
3.4.5. Evaluation of the initial values in the WMTI-Watson model 
After estimating WMTI-Watson model parameters, the filter in the Equation 5.1 was applied to en-
sure that only biologically acceptable values participated in the statistical analysis. However, it was 
noticed in the Figure 3.12 that a substantial amount of voxels were being filtered out in that process, 
with an average of 58±4% of voxels being removed from analysis. This means that these results were 
not entirely reliable and, in addition, tensors and model metrics were being averaged out in fairly differ-
ent ROIs. In this case, the outranged values could not have been caused by partial volume effect due to 
misalignment of structures, because the excluded voxels had unphysical parameter values regardless 
containing white matter, gray matter or CSF. In fact, this could be an issue with the model fitting while 
solving the system of Equations 4.31-35.  
In order to understand what was causing the model to fail in so many voxels, only one option could 
be changed within the model estimation. Thus, retaining the mathematical solution 𝐷𝑎 > 𝐷𝑒,∥, different 
initial values were tested. If the model was diverging because of the starting estimates, other combina-
tions of starting values would provide parameters within the filter conditions. Since the model estimation 
was one of the most time-consuming steps in the pipeline, only two voxels were selected to undergo 
model fitting: one voxel where the model has worked and another from the same dataset were the model 
has failed. The selected voxels are shown in Figure 3.15 where f has not been properly estimated in the 
“unfitting” voxel.  
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Figure 3.15: “Fitting” (upper row) and “unfitting” voxels (lower row) capturing the corpus callosum in three different rep-
resentations (columns): corrected diffusion image (A and D), FA parametric maps (B and E) and f parametric maps (C and 
F). 
 
For a deeper understanding, multiple initial values for each parameter were selected to produce dif-
ferent combinations at each iteration within a nested for loop. These included  𝑓0 = [0.1: 0.2: 0.9], 
𝐷𝑎0 = [0.4: 0.6: 2.8] , 𝐷𝑒,║0
= [0.4: 0.6: 2.8], 𝐷𝑒,ꓕ0 = [0.3: 0.4: 1.9] and 𝜅0 = [1: 2: 11]. Each itera-
tion corresponded to a different set of initial values and for each, a set of parameters was calculated in 
each voxel. Histograms were produced for each parameter after all combinations, with a sample of 
54𝑥6 = 3750 iterations. 
 
3.5. Statistical analysis of diffusion metrics 
Taking all data into consideration, a 4D data matrix was ultimately obtained to compute statistical 
tests. Either for health reasons or data corruption, not all data acquired were eligible for analysis. From 
the 18 (10 STZ + 8 CTL) rats that underwent injection, 1 (STZ) died before the 2 weeks assessment, 
and 2 (1 STZ + 1 CTL) were sacrificed before the 21 weeks assessment because of weight loss. One 
poor quality STZ dataset at 6 weeks was excluded because of a problem with the coil during the scanner. 
In addition, several datasets were excluded from the analysis because of incorrect acquisition. 2 STZ 
and 2 CTL datasets at 2 weeks were discarded, as well as other 2 STZ and 2 CTL datasets at 6 weeks 
and at 21 weeks. Since 8 (4 STZ and 4 CTL) rats were not scanned at 21 weeks in time for the statistical 
analysis of this project, a total of 45 datasets were included in the tests to be described. The reformulated 
experimental timeline with all datasets included in the analysis is presented in the Figure 3.16. 
 
 
Figure 3.16: Updated experimental timeline with the datasets included in statistical tests. Due to poor data quality or health 
reasons, some rat brains could not be included in all time points.  
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Unfortunately, at 21 weeks after injection the sample of datasets was not statistically powerful and 
these three datasets were not included in the tests. Nevertheless, these datasets were included in the 
visualization boxplots to provide the tendency of values in the last time point.  
Statistical analysis approaches were explored considering that this project aims to address white mat-
ter microstructure in two different manners: how STZ rats evolve over time, compared with CTL rats, 
and how both groups differ at each moment in time. Thus, two different statistical tests were carried out 
in Matlab. The mean and standard deviation values of each of the 12 metrics were averaged over each 
of the 4 ROIs labels for each dataset. Study groups and time points were averaged so that statistical tests 
to compare the means in different populations were computed. At each time point, two-tailed t-tests 
were computed to evaluate the differences in the mean of each metric and in each ROI between groups. 
The null hypothesis was that the STZ and the CTL groups at each time point came from independent 
random normal distributed samples with equal means at a 5% significance level. Within each group, a 
one-way ANOVA assessed the variance in the mean of each metric and in each ROI over the experi-
mental timeline. The null hypothesis was that the samples at 2, 6 and 13 weeks of each group were 
drawn from populations with the same mean at a 5% significance level.  
 
3.6. Additional diffusion analysis strategies 
In addition to the strategies proposed to optimize the existing pipeline, two new approaches to ana-
lyse the available data were proposed as well. The strategies proposed are described in the subsequent 
sections and aim at complementing the statistical analysis of the diffusion metrics with new spatio-
temporal information that would ideally support the results obtained from the Section 3.5. Both these 
approaches were developed from scratch and were carried out with the intention of being the starting 
point for new projects.   
 
3.6.1. Gray matter analysis for correlation with white matter metrics 
Gray matter atrophy has been a reported manifestation of AD, alongside with white matter degener-
ation, in several icv-STZ rat studies [8]–[10]. A study has shown that white matter degeneration is an 
intermediate event between early amyloid deposition and late gray matter atrophy [121]. However, it 
remains unclear what trigger white matter degeneration and whether this is immediately anterior to gray 
matter atrophy or they are independent.    
Even though a mathematical model for gray matter is lacking, gray matter microstructure can be 
evaluated with DTI and DKI. In order to disclose the spatio-temporal relationship between white matter 
degeneration and gray matter atrophy, tensors metrics were averaged over gray matter regions: ACC, 
RSC, hippocampus, PPC and MTL. These regions were selected according to their functional associa-
tion with white matter ROIs and to the existing literature [8]–[10], [12], [20]. Labels are represented in 
the Figure 3.17, where the connection between gray matter and white matter ROIs becomes clear. The 
mean DTI and DKI metrics in the gray matter were averaged by study groups and time points.  
 
 
Figure 3.17: Gray matter ROIs in two coronal planes.  
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In the preliminary results, the diffusion metric that showed more significant differences across all 
white matter ROIs was the MK. Therefore, MK in the white matter ROIs was studied as a function of 
the MD in the gray matter ROIs, because this metric is the easiest to predict in such an isotropic medium. 
Among all the ROIs selected herein, diffusion alterations in the cingulum were expected to be related to 
alterations in the RSC and the ACC, alterations in the corpus callosum to alterations in the PPC and the 
MTL and alterations in the fornix and fimbria to alterations in the hippocampus. Thus, scatter plots of 
the variables were computed between the ROIs potentially related. For instance, the MK in the cingulum 
was plotted against the MD in the RSC and so on for the other five relationships. These relationships 
were studied in two ways: variables were divided into time points across all study groups and into study 
groups across all time points. Except for the datasets at 21 weeks after injection across time points, all 
datasets were included in the gray matter analysis.  
The preliminary results have shown that white matter degeneration was reflected by low MK values 
in the STZ group. This would be related to gray matter atrophy in ROIs firstly affected by AD, such as 
the hippocampus. In the CTL group the opposite would be expected. Gray matter atrophy is supposed 
to be translated into high MD and structural development is characterized by low MD. The separation 
of the scatter plots into time points would ideally characterize the temporal degeneration.   
 
3.6.2. Tractography for quality assessment of metrics 
Tractography is one of the most widely used techniques to study the brain connectome because of its 
ability to assess its microstructure. However, the idea of this subproject was to take advantage of avail-
able data. The goal was to reconstruct tracts corresponding to the ROIs of this project and to obtain 
metrics from them. Tractography-derived metrics were expected to have a spatio-temporal pattern sim-
ilar to the diffusion metrics, that would confirm the reliability of the reconstructed tracks. According to 
the literature, constrained spherical deconvolution of FODs is a better solution than DTI-based tractog-
raphy, since it minimizes image noise and resolves crossing fibers, as long as there is high b-value 
diffusion direction sampling [88]. Hence, due to the comprehensive tutorials available, MRtrix 3.0 tools 
were used to perform spherical deconvolution of diffusion data. 
Since this subproject was an experiment and occurred at the end of the traineeship, there was no time 
to include more than 8 (4 STZ and 4 CTL) datasets. Preliminary results showed that at 6 weeks after 
injection, study groups showed almost no differences, whereas at 13 weeks there were numerous differ-
ences between groups. From each time point, 2 datasets belonging to each group were selected and were 
included in the tractography processing pipeline, that was developed from scratch. Evidently, results 
were not statistically powerful but, nevertheless, a tendency could already be perceived.   
Even though diffusion data were already corrected, tractography required isotropic data before com-
puting FODs in order to improve software performance. Images were then upsampled to their minimum 
voxel size, 0.18x0.18x0.18 mm3, using the MRtrix function mrresize. As ROI labels were used as seeds, 
atlases were upsampled as well. The first stage of spherical deconvolution was to estimate the response 
function 𝑅(𝜃) for each dataset, based on diffusion signals and gradient information. The tournier algo-
rithm was used within the dwi2response tool of MRtrix as it combines the provided b-values and direc-
tions to improve angular resolution [122]. The FOD function 𝐹(𝜃, 𝜙) was then estimated by spherical 
deconvolution as given by the Equation 4.37. For this purpose, response functions and the diffusion data 
were inputted in the dwi2fod tool of MRtrix to calculate spherical harmonics coefficients [123].  
An FOD dataset is shown in the Figure 3.18 and accurately represents tracts directions. The body of 
the corpus callosum is shown in the x-direction, the external capsule in the y-direction and the cingulum 
in the z-direction. Moreover, the fimbria is imaged in pink which means that its tracts are oriented in the 
x- and z-directions to meet the fornix in the midline of the brain. The random arrow directions in the 
ventricles further confirms the accuracy of the estimated FOD.   
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Figure 3.18: FOD dataset represented with arrows that characterize the fiber orientation. Orientation is defined by arrow 
color and FOD magnitude by arrow size.   
  
 To compare datasets, correspondence between FODs was necessary [89]. All FOD datasets were 
used to create a study-specific unbiased FOD template with the MRtrix function population_template. 
To build the template, all datasets were considered representative of the population, even though clear 
differences arose in the ventricles size of the STZ group, as previously shown in the Figure 3.13. This 
tool used each FOD dataset to output the deformation field that transforms a specific dataset into the 
general template. These warps were afterwards used to spatially normalize FOD datasets and transform 
them into the new template space. The same warp was applied to masks, labelled atlases and to the 
diffusion-weighted images as well, for visualization purposes. Transformations were enabled by the 
MRtrix function mrtransform [89]. Registration outcomes are shown in the Figure 3.19.  
 
 
Figure 3.19: Registration of FOD datasets (A) to a template generated from original data (B). In C) the FOD datasets was 
transformed into the generated template space.  
 
To finally achieve 3D reconstruction, MRtrix provided a tool with multiple algorithms available, 
named tckgen. From algorithms using deterministic methods such as FACT or path-integral methods, to 
different choices of probabilistic methods, the tool enabled the generation of streamlines and provided 
user-controlled parameters. The algorithm chosen was the iFOD2 that allowed for smoother streamlines 
with a 2nd order integration [124]. Here, a streamline was more probable to follow a path where the FOD 
amplitude was large whereas it may rarely traverse orientations where the FOD was small. 
Four different local tractographies were computed with each ROI label as a seed. The seed could be 
instead selected as a set of coordinates, which would not be ideal for an automated process for a larger 
sample. The remaining parameters, such as the number of streamlines, the step size, the FOD amplitude 
cutoff for terminating tracks and the minimum length of streamlines, were chosen based on a trial-and-
error approach, which was conclusively ROI-dependent. The algorithm seeded streamlines randomly 
within the given label mask until the desired number of streamlines was reached, as long as other criteria 
met the parameters inputted.  
Following tracks generation, a good track isolation required tracking editing techniques that use re-
gion masks to include or exclude streamlines from the tractogram. In practical terms, using tckedit 
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MRtrix tool, inclusion regions and exclusion regions were defined, displaying all streamlines that trav-
erse inclusion regions and excluding any streamlines that traverse exclusion regions. Although it is a 
knowledge-based technique, unwanted contributions can be reduced by placing more seeds. Naturally, 
editing tracks depends on the ROI as well. While the corpus callosum had such a great amount of fiber 
connections and requires more filtering, the cingulum was much straighter forward to isolate. The more 
the branching patterns and orientations a region shows, the more difficult it is to isolate it from other 
regions inherently associated anatomically. In this case, manual intervention was necessary. 
With each tract of interest well defined, it was possible to compute statistics on the streamlines in-
cluded. mrstats from MRtrix provided a histogram of the lengths of each streamline of each tract. Even 
though streamline-based metrics were limited to the parameters selected in the track generation process, 
they apply equally to all datasets and thus, they were relatively unbiased. Additionally, AFD was finally 
estimated for each tract, using the afdconnectivity function from MRtrix.  
Length of streamlines and AFD were averaged for each track of interest for each dataset. A plot of 
the average AFD divided by the average length of streamlines were computed for each track of interest, 
including all 8 datasets. The AFD was normalized because the datasets of the different time points were 
not the same rats. The normalized AFD was expected to decrease in the STZ group over time because 
of white matter degeneration confirmed by the microstructural results, and to be constant or to increase 
in the CTL group. In addition, at each time point, AFD would be higher in the CTL group than in the 
STZ group.  
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4. Results 
 
This chapter is divided into the Section 4.1 that describes the results obtained from testing the pipe-
line optimization strategies; the Section 4.2 that describes the final results from the statistical tests, com-
puted after applying the successful optimization procedures to the existing pipeline; and the Section 4.3 
that describes the results from the additional analysis strategies. In fact, the Sections 4.1 and 4.3 describe 
how the final longitudinal study was improved in terms of reliability and reproducibility.   
 
4.1. Optimization strategies to the existing pipeline 
The alterations proposed to the existing pipeline are described in detail in the Section 3.4 and the 
way they affect the processing pipeline is herein described quantitatively or by visual inspection. Several 
times the subprojects relied on the preliminary results to evaluate the potential improvements. Once 
these improvements were verified and considered an additional value to the analysis, the methodology 
was integrated in the pipeline described in the Section 3.3. For each strategy proposed, a final statement 
declares whether the methodology was implemented in the existing pipeline.   
  
4.1.1. Improvement of white matter labels in the template atlas 
After manually changing the 255-label template atlas, the final version had 276 tissues and more 
accurate white matter regions. The before (A) and after states (B) of the template atlas are shown in the 
Figure 4.1. The mathematical difference between both (C) is equivalent to the overall changes made.   
In the anterior slice of the original rat brain template atlas, red arrows show voxels without an as-
signed label. The improvement consisted in filling in these voxels, especially near white matter regions, 
such as the internal capsule and the fimbria (arrow on the left hand-side) and the corpus callosum, cin-
gulum and the RSC (arrow on the right hand-side). The blue circle evidences the separation into cingu-
lum and corpus callosum, that have led to important findings as different tracts in previous studies [8], 
[9], [19], [34]. In the posterior slice, red arrow points at one of the several new labels drawn, namely the 
hippocampal fissure. The blue circle shows the separation between corpus callosum and external cap-
sule, which is different from the human brain and often confounded.  
Main changes were made on the corpus callosum and fimbria. The improved template atlas allowed 
for an improved atlas in the diffusion space of each dataset and thereby more reliable labels of the ROIs. 
Ultimately, diffusion metrics were less affected by partial volume effect and became more representative 
of the microstructure. This new template atlas was therefore integrated in the registration pipeline.   
 
 
Figure 4.1: Differences between the initial and improved template atlas with particular focus on the white matter regions in 
two coronal planes (rows). Red arrows and blue circles highlight the main differences between both.  
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4.1.2. Semi-automatic brain extraction 
For anatomical extraction of the brain, bet2 and 3dSkullStrip software were evaluated by trial and 
error and the different stages of the optimization method are represented in the Figure 4.2. The first 
column corresponds to the whole head anatomical image and the second and third columns correspond 
to the extracted brain resulting from bet2 and 3dSkullStrip tools, respectively.  
In the first attempt to use these tools, data were unedited in terms of intensity or distortion correction. 
Both tools showed a poor segmentation of brain tissue in the inferior part of the brain, possibly caused 
by an accentuated drop in the signal from top to bottom since the coil was placed on top of the head. In 
order to improve the signal in the inferior portion of the brain, the gross variability in intensity distribu-
tion was removed and tools were tested using the corrected image. Their performance showed that 
whereas bet2 was extracting muscle tissue above and laterally, 3dSkullStrip was clipping too much the 
edges. Conversely, bet2 was able to envelop the bottom of the brain, while 3dSkullStrip stopped the 
surface expansion in the midline of the brain. 
All results considered, it was more important to remove non-brain tissue, as evidenced by the blue 
circle than to capture the spinal trigeminal tracts, pointed out by the red arrow. Therefore, the 3dSkull-
Strip performance was more appropriate in this case and indeed reduced the time consumption in this 
pipeline stage. It was integrated in the pipeline after image reconstruction.  
 
 
Figure 4.2: Comparison between two different tools (columns) for brain extraction before (upper row) and after (lower row) 
intensity correction of anatomical data. The red arrow and blue circle represent the advantages of the corresponding tool. 
  
Regarding brain extraction in diffusion data, the 3dAutomask tool was tested, as shown in the  Figure 
4.3. The original unedited diffusion image of one rat at 13 weeks after injection is represented in A). 
The most significant parameter in this tool was the intensity threshold level (thr) and thus, three increas-
ing threshold levels in B), C) and D) showed a gradual removal of the head tissues around the brain 
(blue circles), at the expense of a poor extraction of the bottom of the brain.  
To make up for this, an increasing amount of dilation steps were used, in E), F) and G) with the 
highest threshold level (thr=0.65). Apparently, it improved the extraction of the bottom of the brain, 
while keeping less non-brain tissue than lower threshold levels. When compared with the manually ob-
tained extracted brain in H), both images seem reasonably similar (green circles), except for the presence 
of a thin layer of non-brain tissue around the extracted brain.   
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Figure 4.3: Comparison between different parameters for the brain extraction in diffusion data. The circles represent the 
main differences between parameters. 
 
To understand how impactful the layer resulting from unsupervised brain extraction (thr=0.65 and 3 
dilation steps) can be, the image in G) underwent all the processing pipeline described in the Section 
3.3. until tensors metrics were calculated. The Figure 4.4 shows the comparison between the denoised 
eddy-corrected images (A and B) and the MK parametric map (C and D) resulting from the pipeline 
computed the manually edited mask and the mask from G). 
In the corpus callosum, different values of the diffusion signal in the exact same voxel were found 
using both masks, which means that noise and distortion corrections accounted for the voxels outside 
the brain to normalize the diffusion image. This had an effect in DTI and DKI measurements, with a 
difference in MK of roughly 0.18, which is highly significant considering the usual differences in MK 
between groups and time points within a ROI.  
 
 
Figure 4.4: Comparison between manual extraction and the 3dAutomask tool with thr=0.65 and 3 dilations in the corrected 
diffusion signal (upper row) and the MK parametric map (lower row) in the corpus callosum. 
 
Therefore, for this method to be integrated into the existing pipeline, there was still need for post-
processing of the extracted brain, to ensure the head tissues were removed from the analysis and the 
parametric maps were as reproducible as possible. It was still less time-consuming to combine the 3dAu-
tomask tool with thr=0.65 without dilation and manually fill in the bottom of the brain. As seen in D) in 
the Figure 4.3, there was no overlapping of non-brain tissue on top of the head. This semi-automatic 
approach was therefore implemented in the existing pipeline. 
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4.1.3. Bias field correction 
The difference between the original unedited anatomical image (A) and the bias field corrected image 
(B) is represented in the Figure 4.5. In the original anatomical data, it is clear a gradient of signal atten-
uation as a function of distance from the coil, i.e. less signal in the bottom of the brain. In turn, the 
corrected image shows deep brain structures with similar intensities to the cortex. With a better contrast 
between structures in both anterior and posterior planes, this additional step affected positively the reg-
istration and therefore was integrated within the existing pipeline.    
 
 
Figure 4.5: Difference between the original anatomical image and after bias field correction in two coronal planes (rows). 
 
4.1.4. FA atlas-based registration of dMRI data 
As an attempt to minimize the effects of enlargement of ventricles in the metrics, the registration 
procedure was repeated with different image modalities for posterior diffusion co-registration and com-
pared with the standard anatomical registration used by the existing pipeline for each ROI. In the first 
stage of this strategy, only linear registration was computed to compare four different methods (FA, 
CCFAx, CCFAy and CCFAz linear registration) between them and with anatomical registration. The 
average ratio of voxels kept in each ROI after the white matter filter is shown for each method in the 
Table 4.1 for CTL and STZ rats, being R a measure of the alignment between labels and the underlying 
structures. A higher ratio means a lower amount of voxels that contain CSF and therefore a potentially 
better alignment. In the Figure 4.6 the differences between methods are shown for each ROI. 
 
R 
Anatomical     
Registration 
Linear Registration 
FA CCFAx CCFAy CCFAz 
CC 
STZ 0.9537 0.9517 0.9489 0.9662 0.9195 
CTL 0.9743 0.9765 0.9763 0.9830 0.9626 
CG 
STZ 0.9937 0.9961 0.9976 0.9980 0.9678 
CTL 0.9906 0.9941 0.9964 0.9994 0.9800 
Fimbria 
STZ 0.6650 0.7073 0.7506 0.6879 0.7683 
CTL 0.8834 0.9055 0.9330 0.8748 0.9167 
Fornix 
STZ 0.9625 0.9640 0.9609 0.9604 0.9515 
CTL 0.9485 0.9668 0.9603 0.9705 0.9563 
Table 4.1: Average R calculated after 5 different linear registration procedures for each ROI in each study group. CC: cor-
pus callosum, CG: cingulum.  
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Figure 4.6: Comparison between the ROIs extracted from atlases resulting from different registration procedures (columns) 
in a STZ dataset in three coronal planes (rows). 
 
The cingulum was the ROI whose voxels were generally less excluded after filtering and the one 
with less differences between CTL and STZ groups throughout all methods. Even though CCFAy was 
the best linear registration method for both study groups, the ratio difference between CCFAy and ana-
tomical registration was only 0.4% in the STZ group and 0.8% in CTL group. Thereby, since the cingu-
lum was barely affected by partial volume effect, there was no need to change the protocol in this case.  
The fornix did not change considerably from one method to another, with the highest ratio difference 
of 1.3% between methods in the STZ group. The best apparent methods at pushing the fornix label out 
of the CSF were the linear FA registration in the STZ group and the linear CCFAy registration in the 
CTL group. Nevertheless, it remained unclear whether any of the procedures did improve the spatial 
normalization of the structure, since there was no consistency across methods. The fornix might not 
have been affected by partial volume effect, but only challenging to register because of its small size 
and low signal. Incoherent changes in the fornix shown by the preliminary results supported the decision 
to continue using conventional anatomical registration to obtain this ROI’s label.  
The corpus callosum was highly affected by the hypersized ventricles, since the STZ group always 
had a lower ratio than the CTL group across the methods. The CCFAy was the map with higher R, which 
was partially expected, since this ROI links the two hemispheres and therefore it mainly diffuses in the 
x- and y-directions. Accordingly, CCFAy and CCFAx had a ratio difference in module of only 1.7% in 
the STZ group. Considering that CCFAy was the only method better than the anatomical registration 
with a ratio difference of 1.2%, it was the method chosen for this ROI to undergo non-linear registration. 
Lastly, as expected, the fimbria was clearly the most affected ROI by ventricle enlargement, with the 
largest ratio difference between groups of 21.8% in the anatomical registration. This means that in the 
STZ group, an average of 82 in 186 voxels was being dramatically left out of the analysis because of 
misalignment issues. Strong improvements were shown by CCFAz in the STZ group and CCFAx in the 
CTL group. In this case, it was noteworthy that even the CTL group underwent partial volume effect 
without having enlarged ventricles, because of the simple fact that the fimbria is closer to the ventricles 
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than any other ROI considered in this study. The ratio difference in the STZ group between CCFAz and 
CCFAx was 1.8%, whereas in the CTL group was 1.6%. After taking a close inspection to the overlaid 
labels in diffusion data, the CCFAz was the method selected to undergo non-linear transformation. 
Hence, the corpus callosum and the fimbria were the most affected ROIs by misalignment caused by 
enlarged ventricles. Non-linear registration was performed with the respective affine matrix as a starting 
estimate for CCFAy and CCFAz data, respectively. The comparison between linear and non-linear reg-
istration in each ROI is shown in the Table 4.2 for CTL and STZ groups and in the Figure 4.7. The 
cingulum and the fornix were not further considered in the analysis. 
 
R Anatomical      Registration 
Registration 
Linear Non-linear 
CCFAy CC 
STZ 0.9537 0.9662 0.9843 
CTL 0.9743 0.9830 0.9847 
CCFAz Fimbria 
STZ 0.6650 0.7683 0.8199 
CTL 0.8834 0.9167 0.8524 
Table 4.2: Average R calculated after linear and non-linear registration of the method selected for the corpus callosum (CC) 
and the fimbria in each study group.  
 
 
Figure 4.7: Comparison between the ROIs (rows) extracted from atlases resulting from linear and non-linear registration 
(columns) of the method selected in the first stage in a STZ dataset.  
 
Except for the CTL group in the fimbria, all non-linear methods overpassed linear registration. In the 
STZ group, the fimbria had a ratio difference between linear and non-linear registration of 5.2% and the 
corpus callosum of 1.8%. Visual inspection confirmed a preference for the non-linear procedure in both 
ROIs, as seen in the green circles. 
Since non-linear CCFAy and CCFAz registration showed improved ratios in the corpus callosum 
and the fimbria, respectively, statistical tests were performed to have a quantification of such improve-
ments. From the preliminary results, t-tests showed more significant differences and therefore only these 
were computed herein. The comparison between differences in metrics obtained in labels from anatom-
ical registration and from the potential improved registration procedure is presented in the Table 4.3 for 
the corpus callosum and in the Table 4.4 for the fimbria. In these tables, p-values are representative of 
the differences between groups at each time point.  
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p-values t-test 
Anatomical               
Registration 
Non-linear CCFAy     
Registration 
CC 
𝑫𝒂 2 weeks 0.0048 0.0181 
𝑫𝒆,║ 6 weeks 0.0460 >0.05 
FA 13 weeks >0.05 0.0002 
AD 13 weeks 0.0237 0.0035 
MK 13 weeks 0.0395 0.0006 
AK 13 weeks 0.0352 0.0013 
RK 13 weeks >0.05 0.0034 
f 13 weeks >0.05 0.0429 
Table 4.3: Comparison between t-tests computed in the preliminary results and with CCFAx in the corpus callosum (CC). p-
values quantify differences between groups at each time point in diffusion metrics. 
 
p-values t-test 
Anatomical               
Registration 
Non-linear CCFAz         
Registration 
Fimbria 
MD 2 weeks 0.0322 0.0081 
RD 2 weeks 0.0061 0.0008 
𝑫𝒂 2 weeks 0.0146 0.0172 
FA 13 weeks 0.0040 0.0057 
MD 13 weeks >0.05 0.0154 
RD 13 weeks 0.0124 0.0022 
MK 13 weeks 0.0033 0.0096 
RK 13 weeks 0.0072 0.0234 
f 13 weeks 0.0237 0.0379 
Table 4.4: Comparison between t-tests computed in the preliminary results and with CCFAz in the fimbria. p-values quantify 
differences between groups at each time point in diffusion metrics. 
 
p-values with lower orders of magnitude are highlighted in green in these tables and with higher 
orders of magnitude in red. In all cases, there are new differences in metrics that were not significant in 
the preliminary results. In the corpus callosum, there was one difference in a metric that lost power with 
non-linear registration. However, not only most significant changes were improved by one or two orders 
of magnitude, but new significant changes were evident as well. Overall, it seemed that the alignment 
of the corpus callosum was optimized with non-linear CCFAy registration, leading to increased statisti-
cal power in the results. The results in the fimbria were equally great, with one difference in a metric 
that lost power after non-linear CCFAz registration, but with several metrics differences being im-
proved. In the most dramatic case of partial volume effect, the ratio of voxel kept in analysis increased 
from 66.5% to 82.0%. Therefore, CCFAy and CCFAy template atlases were added to the registration 
pipeline, where optimization was guaranteed.  
 
4.1.5. Evaluation of the initial values in the WMTI-Watson model 
Several initial values were set in the estimation of the WMTI-Watson model. Each combination of 
initial parameters corresponded to a different iteration that provided a single vector of parameter values 
for the “fitting” and “unfitting” voxels. The parameter values obtained are shown in the histograms in 
the Figure 4.8 for a total of 3750 iterations. The first row is the distribution of parameters in the “fitting” 
voxels while the second row is the distribution in the “unfitting” voxel. 
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Figure 4.8: Histograms of each WMTI-Watson model parameter (columns) in two different voxels (rows) with 3750 combina-
tions of initial values. The window of each parameter comprises parameter values considered to be biophysically reasonable.  
 
In the “fitting” voxel, most iterations, i.e. most combinations of initial parameters, led to the same 
range of solutions. These were, as expected, within the acceptable range of biophysical values that pass 
the criteria for the model to work. However, way less combinations led to that range of solutions in the 
“unfitting” voxel. The iterations that actually worked in this voxel, i.e. where parameters were within 
the biophysically acceptable values, led to a distribution different from the one in the “fitting” voxel. 
This means that the parameters cannot be represented as a function of the initial guesses because no 
combination of values improves the estimation and therefore the problem must lie within the data. 
When an optimization solver completes its task, it sets an exitflag, whose integer value encodes the 
reason the solver has stopped. While successful outcomes set a positive exitflag, unsuccessful outcomes 
set a negative. When this value is equal to zero, it means that the fitting has reached its computational 
limit. Accordingly, the exitflags of each iteration for each voxel are shown in the Table 4.5. It is note-
worthy that there were no successful iterations within the “unfitting” voxel.  
 
Exitflags -2 0 1 
“Fitting” voxel 
 
Number of     
iterations 
1294 879 1577 
   “Unfitting” voxel 
 
1803 1947 0 
              Table 4.5: Number of iterations with each exitflag value for each voxel 
 
Despite having several diffusion encoding directions that allow for the overestimation of the model, 
there might be an additional bias in data provided that different b-values were used in acquisition with 
different sampling directions each. Whereas a 14 T magnetic field might improve the signal amplitude, 
it also increases vibration in turn. The fast EPI acquisition contributes to a high image distortion as well 
and in general, rat data quality is not as accurate as desired.  
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Moreover, the FOV was narrow because of the rat head size, which decreased the SNR. For instance, 
SNR in the “fitting” voxel is roughly 16 whereas in the “unfitting” voxel is 9. This might explain the 
reason that more than half of the voxels of the ROIs are not accounted for in the analysis. Since changing 
the initial values was shown to have little impact in the parameters’ values in the “unfitting” voxel, 
nothing can be done within this project regarding the high exclusion of values in model estimation unless 
different image resolution is pursued. Thus, any strategy was applied to the existing pipeline and this 
issue can only be addressed by changing data acquisition parameters.     
 
4.2. Statistical analysis of diffusion metrics using the optimized pipeline 
Herein, the results of the statistical tests described in the Section 3.5 are shown. The tests were com-
puted on diffusion metrics extracted after implementing the proposed optimization methodologies de-
fined in the Section 3.4 and tested in the Section 4.1. The strategies confirmed to show satisfactory 
results in terms of efficiency of computation, data quality and reliability of metrics were included.  
 
4.2.1. Tensor-derived metrics results 
The most relevant significant differences in the mean values of the metrics derived from the DTI and 
DKI tensors are shown in the Figure 4.9. Other differences were significant, but the metrics represented 
in these boxplots were considered to capture the fundamental significant differences in these metrics. 
All the metrics boxplots and significant p-values are shown in the Appendix A.  
 
 
Figure 4.9: Boxplots of DTI and DKI derived metrics. Significant differences between study groups at each time point are 
shown in red and within groups over time in green. *: p<0.05, **: p<0.01 and ***: p<0.001. 
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It is noticeable that there were more significant differences between groups at each time point than 
over time. Nevertheless, while at 2 weeks and 13 weeks after injection, there were differences between 
groups, at 6 weeks there were no differences between groups at all.  
The differences between groups at 2 weeks after injection were only showed in the fimbria and for-
nix. Interestingly, there were only significant differences in the fimbria at 2 weeks in the radial direction, 
whereas in the fornix significant differences were found in the axial direction. In the fimbria, the STZ 
group had higher RD at 2 and 13 weeks than the CTL group, and in the fornix the STZ group had lower 
AD at 2 weeks than the CTL group. At 13 weeks after injection, in addition to the fimbria and the fornix, 
the corpus callosum and the cingulum showed significant differences as well. In the STZ group, FA was 
significantly lower in these ROIs than in the CTL group. Across the whole brain, there were significant 
differences between groups in the MK at 13 weeks. STZ rats showed a significantly lower MK than the 
CTL rats. Moreover, MK metrics were significantly lower over time in the STZ group between 2 weeks 
and 13 weeks after injection in the cingulum and the fimbria.  
 
4.2.2. WMTI-Watson model metrics results 
The most significant differences in the mean values of the metrics derived from the estimation of the 
WMTI-Watson biophysical model are shown in the Figure 4.10 and Figure 4.11. Other differences were 
significant, but the metrics shown in these boxplots were considered to capture the fundamental differ-
ences in these metrics. All the metrics boxplots and significant p-values are shown in the Appendix A.  
 
 
Figure 4.10: Boxplots of WMTI-Watson model parameters. Significant differences between study groups at each time point 
are shown in red and within groups over time in green. *: p<0.05, **: p<0.01 and ***: p<0.001. 
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Figure 4.11: Boxplots of WMTI-Watson model parameters. Significant differences between study groups at each time 
point are shown in red and within groups over time in green. *: p<0.05. 
 
There were less significant differences in the model derived parameters, which might be due to the 
high amount of voxels being excluded from analysis by the filter in the Equation 5.2. as assessed in the 
Section 4.1.5. As in the previous metrics, there were more significant differences between groups than 
over time and no significant differences in metrics were reported at 6 weeks. At 2 weeks, the STZ group 
had lower 𝐷𝑎 than the CTL group in the corpus callosum and in the fimbria.  
At 13 weeks, 𝐷𝑎 in the STZ group was also lower than the CTL group in the corpus callosum, but 
not at 6 weeks after injection. In contrast, there were only changes in 𝑓 at 13 weeks across all the ROIs 
except for the fornix. 𝑓 was lower in the STZ group than in the CTL group. In addition, between 2 weeks 
and 13 weeks there was a significant decrease in 𝑓 in the STZ group. Finally, 𝐷𝑒,║ was significantly 
lower in the STZ group than in the CTL group in the fimbria at 2 weeks after injection, and between 6 
weeks and 13 weeks it decreased significantly in the corpus callosum.   
 
4.3. Additional diffusion analysis strategies 
Herein are shown the results from the new approaches to analyse diffusion data presented in the 
Section 3.6. These were complementary strategies to the information obtained in the previous section 
and were not subjected to the conventional statistical analysis. Rather than improving the processing 
pipeline, it provides the study with additional information about the microstructure that is expected to 
complement the spatio-temporal pattern found in the white matter diffusion metrics. In case these results 
supported the analysis, these methodologies could be improved in the domain of new projects. 
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4.3.1.  Gray matter analysis for correlation with white matter metrics 
According to the preliminary results, MK decreases significantly over time in the STZ group and it 
is often significantly higher in the CTL group than in the STZ group. This was an expected tendency 
because MK quantifies the complexity of the structure, i.e. a higher MK corresponds to a more devel-
oped tract microstructure. This in turn corresponds to a lower MD. As to evaluate how gray and white 
matter are spatially and temporally affected in terms of microstructure, scatter plots of the MK in the 
white matter vs MD in the gray matter were computed and they are shown in the Figure 4.12. Only three 
of the six relations were found to be relevant.  
 
 
Figure 4.12: Scatter plots of the relationship between degeneration in the white matter and gray matter. This analysis was 
carried out across groups (upper row) and over time (lower row) between regions known to be relevant to AD and anatomi-
cally connected. CG: cingulum, CC: corpus callosum. 
 
Regarding results across groups, it is noticed that higher MK in the white matter corresponds to lower 
MD in the gray matter in the CTL group in the first two relationships. Generally, the CTL group has a 
higher MK and therefore a lower MD, while the STZ group has a lower MK and a higher MD. However, 
a few datasets do not follow this tendency as they belong to different time points after injection. At 2 
weeks, toxicity has not immediately affected all rats and at 6 weeks, there is recovery in STZ rats which 
might explain why some of the datasets have such a high MK or such a low MD. In addition, a higher 
MK can also represent inflammation as was reported in the treated group in previous studies.  
Over time, the relationship between the cingulum and the RSC is representative of the expected re-
sults. At 2 weeks after injection, the cingulum shows a high MK and RSC a low MD, while at 6 weeks 
the cingulum shows a high MK and RSC shows an even lower MD. This refers to the potential recover 
period reported in the literature. At 13 weeks after injection, lower MK of the cingulum corresponds to 
higher MD of the RSC, which represent STZ datasets. Interestingly, the dataset with lower MD is a CTL 
rat at 13 weeks, meaning a situation of full development. 
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In the fornix vs hippocampus, the relationship is not as clear at 13 weeks, but in general results are 
similar and consistent with the results shown in previous sections and with the view that the hippocam-
pus is one of the firstly affected regions in AD. In the corpus callosum versus PPC, at 2 weeks the 
relationship is nothing as expected, with CTL and STZ rats having high MK and high MD. This might 
be meaningful regarding the time and speed at which each tract is affected. In fact, the corpus callosum 
only showed differences in DTI and DKI metrics later in the timeline.  
The spatial pattern of these results is consistent with the interpretation of the preliminary results of 
diffusion metrics. With such a huge amount of data available, the information about the gray matter is 
highly promising. Statistical tests could be computed to reach correlations between regions in space and 
time, providing a new understanding of the progression of AD-like features in the icv-STZ model. A 
model of the microstructure that could extend to the gray matter would be useful in the interpretation of 
changes that were here shown to be a two-edged knife.    
 
4.3.2. Tractography for quality assessment of metrics 
In this context, tractography was performed in order to isolate the 3D tracts of interest and analyse 
the spatio-temporal pattern of AFD in each tract. After computing FODs and performing FOD registra-
tion to the created template, tracks were generated and edited. The automatic generation of tracts was 
complemented with manual editing and the resultant tracts of interest are shown in the Figure 4.13. 
 
 
Figure 4.13: Isolation of tracks of interest after track generation using ROI-editing techniques and manual correction. SSC: 
somatosensory cortex, CC: corpus callosum. 
 
Because of the wide structure of the corpus callosum, three different views were shown to facilitate 
its interpretation. In A), there are seeds in the corpus callosum and external capsule, which is an exten-
sion of this white matter tract, at both hemispheres. Here, it is clear the connection between the basal 
ganglia and the somatosensorial cortex through the corpus callosum and the external capsule. In B) is 
shown another known connection between the motor cortex and the corpus callosum, more posterior 
than A). C) is the complete corpus callosum tract used for metrics estimation. It connects both sides of 
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the brain with multiple ramifications into the cortex. D), E) and F) are the other tracts of interest used in 
the analysis. The cingulum in D) viewed from top consists in two bundles of fibers that traverse the 
brain from front to back, right above the corpus callosum. E) is the fornix from a lateral perspective, 
which forms a C-shaped structure and is connected to the fimbria in F) in the midline of the brain. SSC: 
Somatosensory cortex.  
AFD was estimated in the tracks of interest and averaged for each dataset. Plots of the averaged AFD 
normalized by the average streamlines’ length are shown in the Figure 4.14. 
 
 
Figure 4.14: Plots of the normalized AFD in each tract of interest at each time point. CC: corpus callosum, CG: cingulum. 
 
The cingulum is the track with AFD closer to expected because the AFD in the STZ group is lower 
than in the CTL group at all time points. However, the AFD in the CTL group is decreasing with time. 
The fornix might also be representative because the AFD in the CTL group increases abruptly, but the 
corpus callosum and the fimbria show random tendencies. AFD datasets were clearly not consistent with 
each other nor with the diffusion metrics. This may be due to problems with the processing while creat-
ing the FOD template or during registration of FOD datasets. It was extremely hard to have an automatic 
procedure to isolate tracts and, in some cases, manual editing was necessary. Especially because of 
partial volume effect, the corpus callosum and the fimbria were very different from one dataset to an-
other, as mirrored in the AFD plots.  
Even though none of these metrics were conclusive and track editing has been time-consuming, the 
isolation of tracks was successful considering that this project started with no previous knowledge and 
a completely new processing pipeline had to be learnt. In the future, tracks should be obtained exclu-
sively manually. The metrics extracted from them will clarify whether the processing methodology is 
being correctly followed or if adjustments to the FOD estimation or track generation should be consid-
ered. Naturally, a larger sample is required to provide statistical validation, however this is counter-
productive since a larger sample asks for a more automatized procedure. A lot of work needs to be done 
in this regard and, even though the results of the pipeline were not quite as planned, this assessment can 
be helpful to further develop the methodology. Tractography would be an excellent tool to avoid partial 
volume effect in the estimation of tensors and model metrics if instead of using labels extracted from 
atlases, tracks were used as 3D binary masks.   
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5. Discussion 
 
5.1. White matter microstructural patterns 
In this project, white matter microstructure was assessed longitudinally in icv-STZ rats. Voxel-based 
analysis was computed by calculating DTI and DKI tensors whose extracted metrics are sensitive to the 
underlying changes of the tracts of interest. In addition, parameters were derived from the WMTI-Wat-
son biophysical model of diffusion. The spatio-temporal pattern of these metrics in each ROI was com-
pared between STZ and CTL groups by statistical analysis, where most of the significant differences 
were found between groups at given time points, rather than over time. Regardless, it was possible to 
infer how degeneration of white matter might be evolving after icv-STZ injection and the results were 
consistent with previous studies of this animal model.    
Tensors metrics showed significant differences between groups in the fimbria and fornix as early as 
2 weeks after injection. Whereas differences in the radial direction suggest inflammation or demye-
lination in the fimbria, changes in the axial direction suggest intra-axonal injury of the fornix. From the 
model, STZ rats showed lower intra-axonal diffusivity at 2 weeks in the fimbria and corpus callosum, 
which is indicative of axonal damage. In addition, lower perpendicular extra-axonal diffusivity in the 
STZ group at 2 weeks suggests lower extra-cellular crowding in the fimbria. This result was counter-
intuitive because of the potential inflammation of this tract suggested by tensor metrics. 
At 6 weeks, there were no reports of group differences in any of the metrics, which corresponds to a 
well-established trend in the icv-STZ model. The presence of a recover period normally follows early 
acute damage and precedes definite chronic axonal loss. Accordingly, at 13 weeks tensors metrics 
showed intense significant differences in all ROIs, mainly manifested by lower anisotropy and com-
plexity in STZ rats. This suggests fiber dispersion and degeneration, respectively, in all tracts after the 
recover period. Importantly, the STZ group showed lower complexity over time in all ROIs between 2 
weeks after injection and 13 weeks. Model parameters confirmed axonal loss with lower water volume 
fraction at 13 weeks. Thus, the corpus callosum and the cingulum have shown to be affected later in the 
disease, while the fimbria and fornix were primarily affected, as reported in other studies [8], [9].  
This project confirms that while axonal injury was reported by DTI and DKI sensitive measures, the 
modelling of white matter provided specificity to the underlying changes, allowing for more precise 
interpretations of changes within the icv-STZ brain microstructure. Axonal injury was specifically trans-
lated into intra-axonal damage at 2 weeks after injection and into axonal loss at 13 weeks after injection, 
which is consistent with the non-monotonic changes reported in the icv-STZ model [10]. The Figure 
5.1 shows the final timeline of the patterns found. 
 
 
Figure 5.1: Interpretation of spatio-temporal pattern of diffusion metrics obtained by DTI, DKI and the biophysical model. 
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Unfortunately, the “21 weeks” time point was not statistically powerful by the time of analysis and 
a tendency of future results was not clear. New datasets have been acquired and will undergo image 
processing and analysis soon. Diffusion metrics between groups are expected to be highly different at 
this time point as degeneration has been confirmed at 13 weeks after injection. However, longitudinal 
changes may not arise because both groups start being affected by ageing which might confound micro-
structural metrics.  
 
5.2. Consistency with previous studies 
In parallel with this project, analysis of functional connectivity of the rat brain was computed as well. 
At 2 weeks after injection, significantly lower brain connectivity in the STZ group was found between 
the hippocampus and the ACC [125]. It is noteworthy that the fimbria and fornix are connected to the 
hippocampus and also showed differences at this time point in the microstructural assessment. In addi-
tion, gray matter analysis showed degeneration of the hippocampus early in the disease. Accordingly, a 
previous study has reported neuronal loss at the septum at 4 weeks, which has cholinergic projections 
to the hippocampus [8]. NFT changes were found in the hippocampal area at 12 weeks, followed by the 
presence of diffuse Aβ plaques at 24 weeks in a recent study [9].  
Regarding the potential recovery at 6 weeks, a study of the cognitive performance of the icv-STZ 
model has shown early sudden deficits at 4 weeks after injection, followed by a compensatory process 
up to 12 weeks and a slow progressive chronic decline from 12 weeks on. In the functional connectivity 
analysis, there was also no group differences affecting the default mode network at this time point [125]. 
This was considered a critical point in which pathological processes could not be compensated any 
longer [9] and was confirmed by this study of the white matter microstructure.  
Effectively, at 13 weeks after injection, the PPC showed lower connectivity with the visual cortex in 
the STZ rats than CTL rats [125]. PPC is anatomically connected to the corpus callosum which showed 
lower diffusivity at this time point as well. Moreover, the functional connectivity between the ACC and 
the RSC, regions linked to the cingulum, showed to vary differently over time. STZ rats showed de-
creased ACC-RSC connectivity between 2 and 13 weeks after injection, while this connectivity in-
creased in CTL rats. Furthermore, other studies have reported thinning of the corpus callosum and cin-
gulum in later time points [8], [9]. Gray matter analysis did not reveal a relationship between degenera-
tion of the corpus callosum and atrophy of the PPC at any of the time points. Nevertheless, STZ and 
CTL groups showed different patterns in this relationship which might indicate that the PPC was atro-
phied before the corpus callosum was degenerated at 13 weeks. Contrarily, a relationship between cin-
gulum degeneration and RSC atrophy was pronounced, even though the STZ rats have not shown sig-
nificant microstructural differences in the cingulum at 2 weeks.  
There are several relations between the project here reported and other studies that refer to different 
biomarkers. Not only this fact supports the credibility of this experimental animal model, but it also 
marks the importance of studying the individual impact of each hallmark on the progression of neuro-
degeneration.  
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5.3. Optimization strategies 
Despite being useful in the interpretation of microstructural changes, as aforementioned, the WMTI-
Watson model might not have reached its full potential because of insufficient data quality. Estimation 
performance might have been compromised by the presence of imaging artefacts incapable of being 
removed by the processing pipeline. These artefacts affected the fitting of the model’s equations in such 
a way that nearly 60% of the white matter voxels had unphysical values and were excluded from statis-
tical analysis to avoid influencing the results. This means that there might be other significant differences 
within model parameters or the existing differences might be even more powerful.  
Along with the WMTI-Watson model unfitting, statistical results were partially affected by ventricle 
enlargement, typical of neurodegenerative diseases, which was one of the principal issues within the 
processing pipeline. Simultaneously, the strategy proposed for overcoming the spatial misalignment 
caused by the oversized ventricles was the most successful of the pipeline alterations. The fimbria was 
dramatically affected by partial volume effect with CSF, with 33% of the fimbria label voxels being 
removed from diffusion metrics analysis because they did not pass the white matter filter imposed by 
diffusion metrics intervals. A different registration approach effectively reduced this value to 18% in 
the STZ group. The corpus callosum benefited as well from this methodology, as the white matter filter 
reduced the voxels removed from 5% to 2% in the STZ group. Non-linear transformation of CCFA data 
had a direct impact in the statistical power of longitudinal changes between and within groups by provid-
ing lower p-values by at least one order of magnitude in most of existing differences in metrics. Thus, 
the improvements in the misalignment issues allowed for more reliable metrics. 
Another technique that might be able to minimize partial volume effect is tractography. Within this 
project there was not enough time to use the reconstructed tracts to recalculate diffusion metrics and 
compare with the ROI-based analysis. Nevertheless, the tracts representing the ROIs of this study were 
semi-automatically isolated and validated by the anatomical connections encountered. Even though 
AFD measures were not consistent with the main results, the pipeline needs further development and a 
larger sample is required. Once the pipeline is approved, tractography might bring along new opportu-
nities for analysis of the microstructure and connectivity.  
Apart from the exploratory analysis of the model that did not allow for its estimation optimization, 
all other strategies proposed were successful and therefore implemented in the pipeline to obtain the 
final results. Namely, correspondence between atlas labels and the underlying structure was improved, 
time-consuming steps of the pipeline were semi-automated ensuring the same performance as manual 
processing and noise induced by MRI inhomogeneities was reduced.  
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6. Conclusion 
 
The icv-STZ model was once again validated with the use of MRI derived biomarkers as it has shown 
brain alterations consistent with the ones previously reported. It constitutes an excellent model of spo-
radic AD because it reflects alterations commonly found in the human brain. The time and speed at 
which tracts are affected was different and at later time points more tracts were affected. While rats have 
rarely been assessed with DWI because of the lower image resolution and presence of noisy artefacts, 
this pipeline was able to extract measures longitudinally and spatially distributed as predicted. The 
model parameters combined with tensors metrics offer a unique set of tools for a fairly specific inter-
pretation of changes in diffusion data.  
With a relatively large sample, this project takes part in a soon-to-be interdisciplinary study of the 
rat brain that will allow to establish the pattern of white matter degeneration, reduced functional con-
nectivity, amyloid deposition, brain atrophy and cognitive impairment in function of time after injection 
and brain location. Apart from DWI assessment, rs-fMRI data have been acquired and processed as 
aforementioned, FDG-PET data have already been acquired and histological staining are currently being 
processed. Cognitive performance assessment will be done as well to correlate all the information about 
any type of alterations occurring in rat brain. This will hopefully lead to significant progress in the 
understanding of the very first pathological changes within the brain and their propagation over time 
until clinical evidence arises, in rats developing AD-like features after brain glucose metabolism disrup-
tion. Once the early mechanisms are well characterized and investigations clarify the primary cause of 
the cascade, detection will be possible before symptoms are evident, opening a window for early treat-
ment and AD incidence reduction.  
Overall, the engineering approach was considered helpful for this study as most of pipeline strategies 
adjustments were valuable for estimating more reliable diffusion metrics. Two projects here initiated 
might also be further developed for correlation with all data in current acquisition and/or processing 
within the study. It is recommended to update the processing pipeline occasionally with the most state-
of-art techniques to keep up with other studies and provide trustworthy information for the knowledge 
of AD and neurodegenerative diseases.   
This traineeship met the requirements for the project here presented, as the main task of obtaining 
the longitudinal pattern of white matter microstructure in the icv-STZ rat was completed. Further ad-
vances to the processing pipeline were accomplished and the project outcomes were presented to the 
public at several occasions, as shown in the Appendix B in the Section 8.2. 
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8. Appendices 
 
8.1. Appendix A 
After processing all data using the optimized pipeline, metrics were averaged over ROIs and dis-
played in boxplots over time and divided into study groups (blue: STZ, black: CTL). The patterns of the 
metrics were assessed by two statistical tests that compared means between study groups at each time 
point and over time within each study group. p-values resultant from these statistical tests were used to 
quantify the significance of differences in metrics. In the Section 4.2 the boxplots with the fundamental 
differences were presented in the Figure 4.9, Figure 4.10 and Figure 4.11. Here, all boxplots of DTI 
(Figure 8.1), DKI (Figure 8.2) and model derived metrics (Figure 8.3 and Figure 8.4) are shown, as 
well as the p-values from the t-tests (Table 8.1) and ANOVAs (Table 8.2).  
For instance, the first row of the Table 8.1 means that at 2 weeks after injection there is a very sig-
nificant difference in the mean FA in the fimbria between the STZ and the CTL groups (p<0.01). In the 
respective boxplot in the Figure 8.1, the mean FA in the STZ group is considerably lower than in the 
CTL group. In the Table 8.2 the first row of the table means that within the STZ group, the mean MD 
in the cingulum is significantly different between the “2 weeks” and the “13 weeks” time points 
(p<0.05). In the respective boxplot in the Figure 8.1, the mean MD in the STZ group is considerably 
lower over time. The same is inferred to other significant differences.  
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CTL STZ 
 
Figure 8.1: Boxplots of the metrics derived from DTI (columns) averaged by study groups and time points in each ROI (row). 
Significant differences between and within study groups are shown in the Table 8.1 and Table 8.2. Fundamental differences 
are shown in the Section 4.2.1.  
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CTL STZ 
 
Figure 8.2: Boxplots of the metrics derived from DKI (columns) averaged by study groups and time points in each ROI (row). 
Significant differences between and within study groups are shown in the Table 8.1 and Table 8.2. Fundamental differences 
are shown in the Section 4.2.1.  
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Differences between STZ and CTL groups at each time 
point in tensors metrics 
Time point ROI Tensors metrics p-value 
2w 
Fimbria 
FA 0.0051 
RD 0.0023 
Fornix AD 0.0003 
13w 
CC 
FA 0.0005 
AD 0.0096 
MK 0.0005 
AK 0.0028 
RK 0.0024 
CG 
AD 0.0017 
MK 2.5540e-05 
RK 0.0002 
Fimbria 
FA 0.0008 
MD 0.0058 
RD 0.0006 
MK 0.0013 
AK 0.0224 
RK 0.0048 
Fornix 
MK 0.0489 
AK 0.0182 
Table 8.1: Significant differences (p<0.05) between study groups in metrics derived from DTI and DKI in each ROI and at 
each time point.  
 
Differences within each group over time in tensors metrics 
Study group ROI Tensors metrics p-value 
STZ 
CG 
MD 0.0491 
MK 0.0087 
RK 0.0273 
Fimbria MK 0.0086 
Fornix 
FA 0.0211 
AD 0.0115 
AK 0.0385 
CTL 
CC 
MK 0.0440 
RK 0.0278 
CG 
MK 0.0320 
RK 0.0402 
Table 8.2: Significant differences (p<0.05) over time in metrics derived from DTI and DKI in each ROI and within each 
study group.  
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CTL STZ 
 
Figure 8.3: Boxplots of two metrics derived from the model (columns) averaged by study groups and time points in each 
ROI (row). Significant differences between and within study groups are shown in the Table 8.3 and Table 8.4. Funda-
mental differences are shown in the Section 4.2.2. 
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CTL STZ 
 
Figure 8.4: Boxplots of remaining three metrics derived from the model (columns) averaged by study groups and time points 
in each ROI (row). Significant differences between and within study groups are shown in the Table 8.3 and Table 8.4. Funda-
mental differences are shown in the Section 4.2.2. 
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Differences between STZ and CTL groups at each time 
point in model metrics 
Time point ROI Model metrics p-value 
  2w   
CC   𝑫𝒂   0.0224   
  Fimbria   
𝑫𝒂   0.0043   
𝑫𝒆,⊥   0.0387   
  13w   
  CC   
f   0.0109   
𝑫𝒂   0.0270   
𝑫𝒆,║   0.0349   
  CG  f 0.0004   
  Fimbria   
f   0.0103   
𝑫𝒆,║   0.0319   
Table 8.3: Significant differences (p<0.05) between study groups in metrics derived from the model in each ROI and at each 
time point.  
 
Differences within each group over time in model metrics 
Study group ROI Model metrics p-value 
STZ 
CC 𝑫𝒆,⊥ 0.0273 
CG f 0.0233 
Fornix 𝑫𝒆,║ 0.0252 
CTL Fimbria 𝑫𝒂 0.0383 
Table 8.4: Significant differences (p<0.05) over time in metrics derived from the model in each ROI and within each study 
group.  
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8.2. Appendix B 
In the course of this project, the work developed was published and presented at multiple occasions. 
A chronological list of conference abstracts is here described with brief synopsis of each.   
 
[1] 27th Annual Meeting and Exhibition – ISMRM, 2019, Montreal, Canada 
 
Title: Longitudinal characterization of white matter degeneration in a rat model of brain glucose 
hymetabolism and sporadic Alzheimer’s disease 
Date of submission: November 2018 
Authors: Catarina T. Pereira1, Ting Yin2, Yujian Diao2, Analina R. Silva2, Ileana O. Jelescu2 
1Faculdade de Ciências da Universidade de Lisboa, Portugal; 2Centre d’Imagerie Biomédicale, École 
Polytechnique Fédérale de Lausanne, Switzerland 
Presentation: Accepted for a digital-poster presentation and presented by Ting Yin in May 2019 
 
Synopsis: Impaired brain glucose consumption is a possible trigger of Alzheimer’s disease (AD). 
Animal models can help characterize each contributor to the cascade independently. Here we use the 
intracerebroventricular-streptozotocin rat model of AD in a first-time longitudinal study of white matter 
degeneration using diffusion MRI. Diffusion and kurtosis tensor metrics reveal alterations in the cingu-
lum, fimbria and fornix. The two-compartment WMTI-Watson biophysical model further characterizes 
the cingulum damage as axonal injury and loss - consistent with previous histopathological studies. 
White matter degeneration induced by brain glucose metabolism disruption can bring further insight 
into the role of this mechanism in AD. 
 
[2] 27th Annual Meeting and Exhibition – ISMRM, 2019, Montreal, Canada 
 
Date of submission: November 2018 
Title: Spatio-temporal alterations in functional connectivity in a rat model of brain glucose 
metabolism disruption and sporadic Alzheimer’s disease 
Authors: Yujian Diao1, Catarina T. Pereira2, Ting Yin1, Rolf Gruetter1, Analina R. Silva1, Ileana 
O. Jelescu1 
1Centre d’Imagerie Biomédicale, École Polytechnique Fédérale de Lausanne, Switzerland; 2Facul-
dade de Ciências da Universidade de Lisboa, Portugal 
Presentation: Accepted for a digital-poster presentation and presented by Yujian Diao in May 2019 
 
Synopsis: Impaired brain glucose consumption is a possible trigger of Alzheimer’s disease (AD). 
Animal models can help characterize each contributor to the cascade independently. Here we perform a 
first-time longitudinal study of brain connectivity in the intracerebroventricular-streptozotocin rat model 
of AD. We report altered brain circuitry as early as two weeks in regions notoriously affected by AD 
(cingulate cortices, posterior parietal cortex and hippocampus), and widespread gradual breakdown of 
connectivity with time. The changes in brain connectivity induced by glucose metabolism disruption 
can bring further insight into the role of this mechanism in AD. 
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[3] 25th OHBM Annual Meeting, 2019, Rome, Italy 
 
Date of submission: December 2018 
Title: Longitudinal changes in microstructure and functional connectivity in a rat model of Alzheimer 
Authors: Catarina T. Pereira1, Yujian Diao2, Ting Yin2, Analina R. Silva2, Rolf Gruetter2, Ileana 
O. Jelescu2 
1Faculdade de Ciências da Universidade de Lisboa, Portugal; 2Centre d’Imagerie Biomédicale, École 
Polytechnique Fédérale de Lausanne, Switzerland 
Presentation: Accepted for a paper-poster presentation and presented by myself in June 2019 
 
Synopsis: Impaired brain glucose consumption is a possible trigger of Alzheimer’s disease (AD). 
Animal models can help characterize each contributor to the cascade independently. Here we use the 
intracerebroventricular-streptozotocin rat model of AD in a first-time longitudinal study of white matter 
microstructure and brain connectivity using diffusion MRI and resting-state functional MRI, respec-
tively. Diffusion and kurtosis tensor metrics reveal alterations in the cingulum, fimbria and fornix. The 
two-compartment WMTI-Watson biophysical model further characterizes the cingulum damage as ax-
onal injury and loss - consistent with previous histopathological studies. We further report altered brain 
circuitry as early as two weeks in regions notoriously affected by AD (cingulate cortices, posterior 
parietal cortex and hippocampus), and widespread gradual breakdown of connectivity with time. These 
biomarkers can bring additional insight into the role of these mechanisms in AD. 
